Postoperative residual paralysis in patients aged over 65 years old at the Post-Anesthesia Care Unit

array:24 ["pii" => "S2256208716300244" "issn" => "22562087" "doi" => "10.1016/j.rcae.2016.04.008" "estado" => "S300" "fechaPublicacion" => "2016-07-01" "aid" => "289" "copyrightAnyo" => "2016" "documento" => "article" "crossmark" => 1 "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Rev Colomb Anestesiol. 2016;44:209-15" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1015 "formatos" => array:3 [ "EPUB" => 96 "HTML" => 687 "PDF" => 232 ] ] "Traduccion" => array:1 [ "es" => array:20 [ "pii" => "S0120334716300405" "issn" => "01203347" "doi" => "10.1016/j.rca.2016.04.006" "estado" => "S300" "fechaPublicacion" => "2016-07-01" "aid" => "289" "copyright" => "Sociedad Colombiana de Anestesiología y Reanimación" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Rev Colomb Anestesiol. 2016;44:211-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4563 "formatos" => array:3 [ "EPUB" => 92 "HTML" => 3730 "PDF" => 741 ] ] "es" => array:12 [ "idiomaDefecto" => true "cabecera" => "Investigación científica y tecnológica" "titulo" => "Relajación residual postoperatoria en pacientes mayores de 65 años en la Unidad de Cuidado Postanestésico" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "211" "paginaFinal" => "217" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Postoperative residual paralysis in patients aged over 65 years old at the Post-Anesthesia Care Unit" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Víctor Hugo González-Cárdenas, Kelly Johana Salazar-Ramírez, Gina Tatiana Coral-Sánchez" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Víctor Hugo" "apellidos" => "González-Cárdenas" ] 1 => array:2 [ "nombre" => "Kelly Johana" "apellidos" => "Salazar-Ramírez" ] 2 => array:2 [ "nombre" => "Gina Tatiana" "apellidos" => "Coral-Sánchez" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2256208716300244" "doi" => "10.1016/j.rcae.2016.04.008" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2256208716300244?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0120334716300405?idApp=UINPBA00004N" "url" => "/01203347/0000004400000003/v2_201607220246/S0120334716300405/v2_201607220246/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2256208716300219" "issn" => "22562087" "doi" => "10.1016/j.rcae.2016.04.005" "estado" => "S300" "fechaPublicacion" => "2016-07-01" "aid" => "285" "documento" => "article" "crossmark" => 1 "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Rev Colomb Anestesiol. 2016;44:216-21" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 984 "formatos" => array:3 [ "EPUB" => 95 "HTML" => 652 "PDF" => 237 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "Scientific and Technological Research" "titulo" => "Transcultural and linguistic adaptation of the Richmond Agitation-Sedation Scale to Spanish" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "216" "paginaFinal" => "221" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Validación transcultural y lingüística de la escala de sedación y agitación Richmond al español" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:9 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "fuente" => "Source: Authors." "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1240 "Ancho" => 1652 "Tamanyo" => 56667 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Absolute frequency for each grade using the Spanish version of RASS in 300 evaluations performed." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "José Antonio Rojas-Gambasica, Albert Valencia-Moreno, Víctor Hugo Nieto-Estrada, Pablo Méndez-Osorio, Daniel Molano-Franco, Álvaro Tito Jiménez-Quimbaya, Raúl Escobar-Modesto, Nayibe Cortés-Rodríguez, Liliana Paola Correa" "autores" => array:9 [ 0 => array:2 [ "nombre" => "José Antonio" "apellidos" => "Rojas-Gambasica" ] 1 => array:2 [ "nombre" => "Albert" "apellidos" => "Valencia-Moreno" ] 2 => array:2 [ "nombre" => "Víctor Hugo" "apellidos" => "Nieto-Estrada" ] 3 => array:2 [ "nombre" => "Pablo" "apellidos" => "Méndez-Osorio" ] 4 => array:2 [ "nombre" => "Daniel" "apellidos" => "Molano-Franco" ] 5 => array:2 [ "nombre" => "Álvaro Tito" "apellidos" => "Jiménez-Quimbaya" ] 6 => array:2 [ "nombre" => "Raúl" "apellidos" => "Escobar-Modesto" ] 7 => array:2 [ "nombre" => "Nayibe" "apellidos" => "Cortés-Rodríguez" ] 8 => array:2 [ "nombre" => "Liliana Paola" "apellidos" => "Correa" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0120334716300326" "doi" => "10.1016/j.rca.2016.04.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0120334716300326?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2256208716300219?idApp=UINPBA00004N" "url" => "/22562087/0000004400000003/v1_201607020109/S2256208716300219/v1_201607020109/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2256208716300268" "issn" => "22562087" "doi" => "10.1016/j.rcae.2016.05.002" "estado" => "S300" "fechaPublicacion" => "2016-07-01" "aid" => "291" "documento" => "article" "crossmark" => 1 "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Rev Colomb Anestesiol. 2016;44:201-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1049 "formatos" => array:3 [ "EPUB" => 106 "HTML" => 705 "PDF" => 238 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "Scientific and Technological Research" "titulo" => "Characterization and analysis of adverse events in closed liability cases involving anaesthetists who received legal support from the Colombian Society of Anaesthesia and Resuscitation (S.C.A.R.E.), Colombia, 1993–2012" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "201" "paginaFinal" => "208" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Caracterización y análisis de eventos adversos en procesos cerrados de anestesiólogos apoderados por la Sociedad Colombiana de Anestesiología y Reanimación (S.C.A.R.E.) en Colombia entre 1993–2012" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:9 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "fuente" => "Source: the authors." "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1440 "Ancho" => 1587 "Tamanyo" => 96458 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Case selection for the analysis." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Juan Carlos Bocanegra-Rivera, José Hugo Arias-Botero" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Juan Carlos" "apellidos" => "Bocanegra-Rivera" ] 1 => array:2 [ "nombre" => "José Hugo" "apellidos" => "Arias-Botero" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0120334716300454" "doi" => "10.1016/j.rca.2016.04.008" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0120334716300454?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2256208716300268?idApp=UINPBA00004N" "url" => "/22562087/0000004400000003/v1_201607020109/S2256208716300268/v1_201607020109/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "Scientific and Technological Research" "titulo" => "Postoperative residual paralysis in patients aged over 65 years old at the Post-Anesthesia Care Unit" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "209" "paginaFinal" => "215" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Víctor Hugo González-Cárdenas, Kelly Johana Salazar-Ramírez, Gina Tatiana Coral-Sánchez" "autores" => array:3 [ 0 => array:4 [ "nombre" => "Víctor Hugo" "apellidos" => "González-Cárdenas" "email" => array:1 [ 0 => "vhgonzalez@fucsalud.edu.co" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "c" "identificador" => "aff0020" ] 2 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Kelly Johana" "apellidos" => "Salazar-Ramírez" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0015" ] 1 => array:2 [ "etiqueta" => "c" "identificador" => "aff0020" ] ] ] 2 => array:3 [ "nombre" => "Gina Tatiana" "apellidos" => "Coral-Sánchez" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0015" ] 1 => array:2 [ "etiqueta" => "c" "identificador" => "aff0020" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "MD, Anesthesiologist, Clinical Epidemiologist, Associated Professor at the Fundación Universitaria de las Ciencias de la Salud (FUCS), and Universidad de La Sabana, Fundación Hospital Infantil Universitario de San José, Bogotá D. C., Colombia, Bogotá D.C., Colombia" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "MD, Anesthesiologist Resident, Universidad de La Sabana, Chía, Colombia" "etiqueta" => "b" "identificador" => "aff0015" ] 2 => array:3 [ "entidad" => "Research Groups in Anesthesia Deorum Opus - Fundación Universitaria de Ciencias de la Salud / Fundación Hospital Infantil Universitario de San José / and Mandrágora, Hospital Universitario de la Samaritana" "etiqueta" => "c" "identificador" => "aff0020" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author at: Fundación Hospital Infantil Universitario de San José, Oficina de Anestesiología, Carrera 52 # 67 A 71, Cuarto Piso, Bogotá, Colombia." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Relajación residual postoperatoria en pacientes mayores de 65 años en la Unidad de Cuidado Posanestésico" ] ] "textoCompleto" => "IntroductionNeuromuscular relaxation is mainly used to facilitate orotracheal intubation, for improved visualization and manipulation of the surgical field, and to optimize the patient–ventilator interaction when appropriate.<a class="elsevierStyleCrossRefs" href="#bib0105">1,2</a>Notwithstanding the considerable benefits of these drugs, they may lead to post-operative residual paralysis (Rp).<a class="elsevierStyleCrossRefs" href="#bib0105">1–3</a> The recommendation is to make the diagnosis using quantitative criteria to assess the function of the neuromuscular junction through peripheral nerve stimulation that guides our choice of a safe neuromuscular relaxation therapy and helps to optimize the pharmacological reversal measures.<a class="elsevierStyleCrossRefs" href="#bib0105">1–3</a>According to the study, the incidence of residual paralysis ranges from 2% to 88%.<a class="elsevierStyleCrossRefs" href="#bib0105">1,4,5</a> In the opinion of Donati,<a class="elsevierStyleCrossRef" href="#bib0120">4</a> this number is closer to 57%, averaging the results from the trials by Murphy, Naguib, Kumar, Butterly and Thilen, reported between 2007 and 2012. It should be stressed however, that based on this study, only 1% of anesthetists actually consider the problem.<a class="elsevierStyleCrossRefs" href="#bib0130">6–10</a>Residual paralysis is relevant because it may go unnoticed during the post-anesthesia recovery period, giving rise to severe respiratory post-operative complications associated with longer extubation times, risk of re-intubation, bronchoaspiration, extended recovery, delayed PACU discharge, and even more severe life-threatening conditions.<a class="elsevierStyleCrossRefs" href="#bib0105">1,3,5–7,11</a>There is a wide range of studies worldwide but usually they fail to consider the population over 65 years of age. These so-called “elderly” patients usually present an impaired organ ability to clear medications and increased sensitivity in terms of length and depth of the relaxation effects that may result in additional economic and healthcare burden.<a class="elsevierStyleCrossRef" href="#bib0160">12</a> In fact, the Polish trial by Pietraszewski et al.,<a class="elsevierStyleCrossRef" href="#bib0160">12</a> describes the higher Rp incidence in patients aged 65 through 89, in contrast with patients between 19 and 57 years old (44% vs. 20%), and even higher rates of hypoxia when comparing both groups (17.9% vs. 8.2%).The incidence of Residual Paralysis is yet unknown, particularly when referring to people over 65 years of age, since the statistics reported for this age group are meager.Based on the above statements and considering the major impact of evaluating both the incidence and current management of Rp in patients over 65 years old, we tried to respond the following question: “What is the incidence of Rp in patients over 65 years of age, exposed to nondepolarizing neuromuscular relaxants? Which are the characteristics of the current treatment for residual paralysis in patients aged 65 and older?The key objective in trying to answer these questions was to estimate the incidence of Rp in patients over 65 years old, exposed to nondepolarizing relaxants, and then to discuss the effectiveness of pharmacological reversal therapy.Materials and methodsAnalytical, observational, cohort-based trial at the Samaritana University Hospital and the San Jose University Children's Hospital Foundation, between 2014 and 2015. The cohort inclusion criteria included: patients over 65 years old exposed to nondepolarizing neuromuscular relaxants. All patients discharged from the ICU with mechanical ventilation were excluded.The patients enrolled in the trial were conveniently selected in consecutive order based on the surgical schedule of the research institution. Only the records that met the selection criteria and were fully compliant with the Stockholm Consensus were included in the analysis.<a class="elsevierStyleCrossRef" href="#bib0165">13</a>Residual paralysis was defined as a train of four (TOF) ratio between the first and the last motor response (T4/T1) of less than 90%. This measurement was taken according to the parameters under the Stockholm Consensus<a class="elsevierStyleCrossRef" href="#bib0165">13</a> using two different approaches: TOF-Watch SX (TOF-Watch XS Device, Organon, Oss, The Netherlands). Single-use disposable electrodes were placed over the skin on the cubital nerve after cleaning thoroughly a 2–3cm2 surface. The accelerometer was placed on the pulp of the first digit making sure that the hand movement was artifact-free for an unbiased accelerometer reading. A measurement was taken at the time of admission to the OR, at the end of surgery, prior to extubation, and when the patient was admitted to the recovery room. In case of reversal of the residual paralysis, the necessary TOF measurements were taken from the time of the initial administration of the agent, until a value of over 90% was obtained. This period of time was the time required for total reversal of the residual paralysis. It is important to highlight that the arm used for taking the measurements was immobilized during the measurements and the medications used were administered via a separate line. The measurements were taken by one of the three principal researchers participating in the trial and were masked and independent from medical care.The clinical predictors for residual paralysis were evaluated at two different times: pre-extubation and at the time of admission to the recovery room. Some of the tests administered included the ability to hold the head up for more than five seconds, the presence of apnea, compliance with the ventilation extubation criteria, and the ability to speak easily.Our primary objective was to measure the incidence of residual paralysis in the OR prior to extubation and at the time of admission to the recovery unit, in addition to evaluating the severity of the residual paralysis in association with clinical signs measurements for the recovery of the neuromuscular junction. In every case any residual paralysis-related complications were mentioned, in addition to the pharmacological reversal, including the need to admit the patient to the ICU.Based on the world literature, we estimated that 228 records had to be assessed in order to obtain a 51.5% likelihood of Rp, with a 95% CI and a 6.5% accuracy.The data recorded included demographics (age, gender, body weight, height), pre-surgical information (comorbidities, use of pre-anesthesia drugs, surgical diagnosis, and intra-operative variables such as IV anesthetic agents, inhaled anesthesia, antibiotics, GI protective agents, antiemetics, and divalent electrolytes, in addition to the neuromuscular relaxants studied at full and body weight estimated doses).The TOF and TOF-T4/T1 protocol measurements were recorded and the latency time required for a value of less than 25% was measured. Similarly, the relaxation strategy (infusion or bolus), the need for additional doses, the time elapsed from the first to the last dose prior to extubation, were all analyzed. The clinical predictors for Rp were also considered and their concordance was evaluated using Kappas. Moreover, accuracy (sensitivity and specificity) and behavioral (positive and negative predictive value) tests were estimated, versus the TOF-based Rp diagnosis.When reversal of the residual paralysis was used, a record was made of the pharmacological strategy used by the physician responsible for the patient in the recovery room or the OR, including the dose and recovery times. Any reversal-associated complications were monitored for at least 2h by one of the three principal researchers participating in this trial.The additional confounding variables included trans-operative crystalloid volume in mL, trans-operative temperature and TOF measurements during residual paralysis reversal.The quantitative statistics were presented according to their respective area, using central trend measurements (median or mean values) and scatter (ranges or standard deviation) depending on their distribution; the qualitative variables were presented in absolute frequencies and percentages. The various hypotheses were compared based on the statistical requirements, using the Ji2 test to compare qualitative variables and Student-T test or U Mann–Whitney for quantitative variables. When required, the impacts and the 95% CI were estimated. The correlation coefficients were evaluated for ordinal data using RHO Spearman and statistical significance. The R2 was measured and reported as needed. The statistical significance was based on p<0.05, and the statistical package used for data processing was STATA 12.0.ResultsPrior authorization of the Technical Committee and of the Ethics Committee for research on human beings of the Samaritana University Hospital and the San Jose University Children's Hospital Foundation, in addition to the Research Sub-commission of the School of Medicine of the Sabana University, 228 complete records that met the selection criteria were included in the analysis; these are listed in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>.<elsevierMultimedia ident="tbl0005"></elsevierMultimedia>When describing the demographics of the patients with Rp prior to extubation and admission to the recovery room, vs. those with no residual relaxation, no statistically significant differences were identified between the two groups (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>).<elsevierMultimedia ident="tbl0010"></elsevierMultimedia>The incidence of residual paralysis in each situation and its intensity are described in <a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>, together with the stratified Rp incidences for each neuromuscular relaxant used. <a class="elsevierStyleCrossRef" href="#tbl0020">Table 4</a> illustrates the mean dose of each relaxant used, the percentage use with a 95 ED and the percentage of use at doses slightly below 95 ED. Additionally, the latency measured under the protocol parameters is shown for 156 valid records.<elsevierMultimedia ident="tbl0015"></elsevierMultimedia><elsevierMultimedia ident="tbl0020"></elsevierMultimedia>The clinical evaluation of Rp showed a very poor correlation between the TOF value and the presence of clinical predictors for Rp. When evaluating based on Searman Rho coefficient, clinical pre-extubation criteria and the presence of Rp diagnosed by TOF the result was Rho=0.137, while in terms of the presence of clinical criteria at admission to the recovery room and the presence of Rp diagnosed by TOF the Rho=−0.052. Furthermore, when evaluating the accuracy and the behavior of each individual criterion both at the time of pre-extubation and at admission to the recovery room, we evidenced poor diagnostic accuracy in each case (<a class="elsevierStyleCrossRef" href="#tbl0025">Table 5</a> shows the sensitivities, the PPV (positive predictive value), and the Kappa coefficients for each test).<elsevierMultimedia ident="tbl0025"></elsevierMultimedia>Additionally, prior to extubation the following Kappa coefficients were estimated: raising head (−0.073), apnea (−0.031), speaking (−0.06), and ability to ventilate properly (−0.01). At admission to the recovery room, the following Kappa coefficients were estimated: raising head (−0.022), apnea (0.007), speaking (0.006), and ability to ventilate properly (0.002).Finally, the use of each pharmacological reversal therapy, their mean doses, effectiveness achieved, and latency minutes required for satisfactory reversal in each group were specified (<a class="elsevierStyleCrossRef" href="#tbl0030">Table 6</a>).<elsevierMultimedia ident="tbl0030"></elsevierMultimedia>DiscussionThe study of post-operative residual paralysis (Rp) has become increasingly relevant during the past decade; the growing use of neuromuscular junction function monitors and the publication of several studies stressing the importance thereof, have given rise to a broad diagnostic spectrum for preventing Rr-associated post-operative complications.<a class="elsevierStyleCrossRef" href="#bib0120">4</a>The information on the incidence of residual relaxation and its associated factors prior to the advent of neurostimulation lacked a strong analytic foundation to establish direct causality. After the introduction of relaxation monitoring with TOF in the 1970s, the incidence of Rp apparently declined, and although the analytic methods measuring TOF gained validity, the considerably varying incidences identified by different authors have failed to provide global and reliable data applicable to all populations.Three different techniques may be used to monitor the neuromuscular junction: electromyography, mechanomyography, and acceleromyography. The latter is the foundation for modern anesthesia monitoring which is convenient, economic, and highly correlated with other more sensitive evaluation approaches such as the results from mechanomyography.<a class="elsevierStyleCrossRefs" href="#bib0115">3,11,14,15</a> It is important to state that the method used in our trial was acceleromyography, since this is the standard measurement method in the OR.Multiple studies have shown that qualitative monitoring is not associated with quantitative measurements. In fact, the latter have been described as measurements that are independent from the clinical signs of complete neuromuscular relaxation. In our study we found no correlation between TOF monitoring and the clinical criteria often used in anesthesiology to predict adequate performance of the junction at the end of surgery (RHO Spearman=0.137), and the same parameters with regards to the TOF value measured at the time of admission to the recovery room (RHO Spearman=−0.052). These are proven facts of very poor sensitivities, PPV and Kappa for every clinical predictor. (See <a class="elsevierStyleCrossRef" href="#tbl0030">Table 6</a>).In terms of the patients enrolled in this analysis, the incidence of residual paralysis prior to extubation was 23.2%, and 9.2% at the time admission to the recovery room. These values are lower than those measured by Fortier et al.<a class="elsevierStyleCrossRef" href="#bib0125">5</a> (Metaanalysis – 2015); in this case the incidence of residual paralysis was 63.5% prior to extubation and 56.5% at the time of admission to the recovery room.Debaene et al.<a class="elsevierStyleCrossRef" href="#bib0105">1</a> determined the percentage of residual paralysis in the recovery room, and found that the incidence of patients with TOF<0.9 (acceleromyography) following a single dose of intubation (equivalent to two effective 95 doses, ED95) at the tie of admission to the recovery room was 45%, and 37% 2h later (in the same unit).Murphy et al., based on clinical and acceleromyography criteria, estimated the residual paralysis at 88% of the patients prior to extubation or immediately after extubation and 32% of these patients in the recovery room with TOF<0.9, despite meeting the clinical criteria.It is striking that none of the trials considered to be of clinical value and previously referred to in this discussion, weigh the severity of the paralysis measured before extubation and that measured in the recovery room. In our records based on the classification published in 2014 by Lien and Kopman<a class="elsevierStyleCrossRef" href="#bib0180">16</a> and in 2007 by Fuchs-Buder et al.<a class="elsevierStyleCrossRef" href="#bib0165">13</a>, we classified the Rp into intense (no response even following a tetanic impulse); profound (TOF<1 but with post tetanic Twitch response); moderate (TOF between 1 and 3); and recovering (any TOF-T4/T1 value). So in our patients in the OR prior to extubation, only 1.9% were classified as moderate and the remaining 98.1% recovering, whilst in the recovery room 100% of the patients had a TOF>3 (indicative of recovering).When analyzing the booster doses for adequate intraoperative relaxation and the cases of Rp prior to extubation and recovery room, no statistically significant differences were identified for either scenario (p=0.29 prior to extubation and p=0.16 in the recovery room). Apparently, the impact of these booster doses was not necessarily associated with an increased Rp frequency. The time elapsed since the last dose did not show a significant correlation when compared against the TOF values prior to extubation and at admission to the recovery room (RHO Spearman=0.184 and 0.187 respectively). These findings suggest that the time between the last dose and the quantitative TOF-T4/T1 value are not associated but are independent when weighing the risk of Rr in our patients.An important consideration is that in our setting, despite the frequent use of nondepolarizing neuromuscular relaxants, a protocol is not followed and exclusively depends on the anesthetist's skill. However, it should be kept in mind that practically in every case the dose in these patients did not exceed the level indicated for intubation (twoED95); on the contrary, it was even slightly lower than the estimated level (see <a class="elsevierStyleCrossRef" href="#tbl0020">Table 4</a>).When evaluating the NMR used by subgroup, the incidence of pre-extubation Rp was 26.6% for Rocuronium; 14.3% for Cisatracurium; and 52.6% for Vecuronium, differing significantly from one-another (p=0.001). In contrast, the incidence of Rp in the recovery room was of 8.3% for Rocuronium; 9.2% for Cisatracurium; and 15.8% for Vecuronium; these differences however are not statistically significant (p=0.728).When contrasting the incidences with Rocuronium versus Cisatracurium, at the time of extubation we found that the values were significantly different (p=0.022); a similar situation occurred when comparing the incidence of Rp with Cisatracurium and Vecuronium (p=0.001). Apparently the incidence of Rp with Cisatracurium is more beneficial for patients than with the other agents. While we may suggest that Cisatracurium was associated with a lower number of patients with Rp, we cannot conclude that the quality or the depth of relaxation during surgery were superior since that appreciation was beyond the scope of our study but these outcomes are indeed relevant when deciding which agent should be used.The Colombian regulations governed by INVIMA ensure the equivalence of the molecules and apparently similar efficacy for our population. However, it should be mentioned that different brand names for each pharmaceutical product were used in this trial, except for Sugammadex; this fact may contribute to the difference in the values reported in the world literature that questions the pharmacokinetics of generics versus original products. Consequently, the results from our research, in addition to being novel, may represent evidence of a potential non-variation in the expected results for our patients, and are different from the outcomes reported by the pharmaceutical companies. This may attest to the clinical similarity of the various molecules regardless of their origin, production, or manufacturing methods, endorsing the technical opinion initially stated and consistent with the publications for other researchers such as Reyes et al.<a class="elsevierStyleCrossRef" href="#bib0185">17</a>.Different complications from residual relaxation due to poor airway protection, declining response to hypoxia, upper airway obstruction and decompensation of the genio-glossus muscle have been identified; this is all associated with extended intubation, risk of re-intubation, or bronchoaspiration, delayed recovery, and delayed discharge from the recovery room, inter alia.<a class="elsevierStyleCrossRefs" href="#bib0125">5–7,3,18</a> In this trial, notwithstanding the large number of patients who presented Rp in the recovery room, only one of them experienced a complication (laryngospasm) that represented 4.76% of the cases, but was not associated to any other outcomes or ICU requirements.In order to prevent all these complications in clinical practice, we have medications available that can revert any residual paralysis. The most commonly used at the national level are the acetylcholinesterase inhibitors (Neostigmina) and Sugammadex.The decision to administer one or the other is based on the severity of the Rp. The current literature states that the principal disadvantage of Neostigmine is its failure to effectively treat intensive and profound residual relaxation; this is contrary to the results reported with Sugammadex, of proven efficacy for any Rp condition, regardless of intensity, but with a higher cost and no proven effect over the benzilisoquinolone-like nondepolarizing relaxants such as Cisatracurium.<a class="elsevierStyleCrossRefs" href="#bib0120">4,19</a>In our study, the decision to reverse the residual paralysis was made individually by each anesthetist; the efficacy evaluation of the strategy used was 89.4% success rate in patients treated with Neostigmine plus Atropine, and of 100% in patients treated with Sugammadex. For Neostigmine and Atropine, the mean recovery time to T4/T1>90% was 5.07min (ED=2.58min) while for Sugammadex was 4.29min (ED=3.82min). The differences were not statistically significant (p=0.522), and we feel there of no clinical relevance. However, one of our patients experienced a waiting time to achieve TOF>0.9 with Sugammadex of 17min. In the light of our current knowledge this event is beyond our understanding, despite the good clinical practices and pharmacovigilance of the institution where the event happened.Although nausea and vomiting have been consistently reported immediately after the administration of Neostigmine and Atropine, only one patient in the trial experienced this side effect, which could be associated not just with exposure to the agent, but with multiple other uncontrolled factors. It is important to note that in contrast to other publications on the subject, none of our patients experienced any hemodynamic complications or arrhythmias requiring further intervention.ConclusionsThe incidence of residual paralysis associated with nondepolarizing neuromuscular relaxants in patients over 65 years old, prior extubation and admission to the Recovery Room was below the number reported worldwide. Residual paralysis reversal was equally effective when comparing Neostigmine versus Sugammadex, with the latter exhibiting a 10% higher clinical latency. We do not discuss any side effects requiring ICU care or additional interventions. We only focused on the quantitative monitoring of the neuromuscular junction function as the key for the safe management of the nondepolarizing neuromuscular relaxant, both to evaluate recovery and reversal therapy, given the significant non-correlation between the clinical values and the data of this monitoring exercise.Although Sugammadex exhibits multiple advantages as compared to Neostigmine,<a class="elsevierStyleCrossRef" href="#bib0200">20</a> our data may suggest that the major benefit is in situations of profound or intense blockade where the use of Neostigmine is controversial. However, for reversal of recovering patients, the administration of Neostigminemay offer similar results and safety as Sugammadex, except for patients with contraindications or controversial use. Rp and reversal-associated cardiac or respiratory complications were not relevant for the patients in this trial. It should be said however that not all patients underwent pharmacological reversal for Rp; in fact, 46.15% of the cases did not receive any medication since clinical monitoring and oxygen therapy were enough to revert the Rp with no complications. So the question arises: Is reversal of Rp with nondepolarizing neuromuscular relaxants really necessary in patients over 65 years of age, when residual relaxation presents during the recovery phase of neuromuscular relaxation?Ethical disclosuresProtection of human and animal subjectsThe authors declare that no experiments were performed on humans or animals for this study.Confidentiality of dataThe authors declare that no patient data appear in this article.Right to privacy and informed consentThe authors declare that no patient data appear in this article.Conflict of interestThe authors have no conflicts of interest to declare.FundingThis study was funded by the researchers and their research groups." "textoCompletoSecciones" => array:1 [ "secciones" => array:13 [ 0 => array:3 [ "identificador" => "xres679464" "titulo" => "Abstract" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Objective" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Methodology" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Results" ] 4 => array:2 [ "identificador" => "abst0025" "titulo" => "Conclusions" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec685423" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres679465" "titulo" => "Resumen" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0030" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0035" "titulo" => "Objetivo" ] 2 => array:2 [ "identificador" => "abst0040" "titulo" => "Metodología" ] 3 => array:2 [ "identificador" => "abst0045" "titulo" => "Resultados" ] 4 => array:2 [ "identificador" => "abst0050" "titulo" => "Conclusiones" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec685424" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Materials and methods" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "Results" ] 7 => array:2 [ "identificador" => "sec0020" "titulo" => "Discussion" ] 8 => array:2 [ "identificador" => "sec0025" "titulo" => "Conclusions" ] 9 => array:3 [ "identificador" => "sec0040" "titulo" => "Ethical disclosures" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0045" "titulo" => "Protection of human and animal subjects" ] 1 => array:2 [ "identificador" => "sec0050" "titulo" => "Confidentiality of data" ] 2 => array:2 [ "identificador" => "sec0055" "titulo" => "Right to privacy and informed consent" ] ] ] 10 => array:2 [ "identificador" => "sec0030" "titulo" => "Conflict of interest" ] 11 => array:2 [ "identificador" => "sec0035" "titulo" => "Funding" ] 12 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2015-07-08" "fechaAceptado" => "2016-04-14" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec685423" "palabras" => array:5 [ 0 => "Muscle relaxation" 1 => "Neuromuscular blocking agents" 2 => "Recovery room" 3 => "Aged" 4 => "Anesthesia" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec685424" "palabras" => array:5 [ 0 => "Relajación muscular" 1 => "Bloqueantes neuromusculares" 2 => "Sala de recuperación" 3 => "Anciano" 4 => "Anestesia" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "IntroductionFew studies have been made on the incidence of residual paralysis from non-depolarizing relaxants in people over 65 years old; however, estimating the number of cases and treatment thereof are both important. ObjectiveTo study the incidence of residual paralysis with non-depolarizing relaxants in patients over 65 years of age and discuss treatment. MethodologyAnalytical observational study based on a cohort design. ResultsThe pre-extubation residual paralysis was estimated at 23.2% and at 9.2% at patient admission to the Recovery Suite. Pharmacological reversal showed 89.4% and 100% success rates with Neostigmine and Sugammadex respectively, with similar times at T4/T1>0.9. ConclusionsThe incidence of pre-extubation residual paralysis was lower than the figure published worldwide. Pharmacological reversal therapies were typically highly effective." "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Objective" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Methodology" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Results" ] 4 => array:2 [ "identificador" => "abst0025" "titulo" => "Conclusions" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "IntroducciónLa incidencia de Relajación Residual por relajantes no despolarizantes en mayores de 65 años ha sido poco estudiada, siendo relevante su calculo y su tratamiento. ObjetivoEstudiar la incidencia de Relajación residual en pacientes mayores de 65 años con relajantes neuromusculares no despolarizantes y describir su tratamiento. MetodologíaEstudio Observacional Analítico con Diseño de Cohorte. ResultadosLa Relajación Residual pre-extubación fue del 23.2% y al ingreso a la Sala de Recuperación del 9.2%. La reversión farmacológica con Neostigmina exhibió un éxito del 89.4% y con Sugammadex del 100%, con similares tiempos a una T4/T1>0.9. ConclusionesLas incidencias de Relajación Residual pre-extubación y en la Sala de Recuperación fueron mas bajas que las publicadas a nivel mundial. Las terapias de reversión farmacológica se distinguieron por su alta eficacia." "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0030" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0035" "titulo" => "Objetivo" ] 2 => array:2 [ "identificador" => "abst0040" "titulo" => "Metodología" ] 3 => array:2 [ "identificador" => "abst0045" "titulo" => "Resultados" ] 4 => array:2 [ "identificador" => "abst0050" "titulo" => "Conclusiones" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "Please cite this article as: González-Cárdenas VH, Salazar-Ramírez KJ, Coral-Sánchez GT. Relajación residual postoperatoria en pacientes mayores de 65 años en la Unidad de Cuidado Posanestésico. Rev Colomb Anestesiol. 2016;44:209–215." ] ] "multimedia" => array:6 [ 0 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "kg: kilograms; BMI: body mass index; TOF: train of four.Source: Authors." "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Variable \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">n=228 Average (range/ED) or frequency (%) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Age (years) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">72 (±29) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Gender (male) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">108 (47.4%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Weight (kg) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">60 (±56) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">BMI (kg/m2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">24.64 (±3.29) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Comorbidities \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (±4) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Prior TOF \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">100 (±13) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1115439.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Demographic information and TOF prior to exposure." ] ] 1 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at2" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "kg: kilograms; BMI: body mass index; TOF: train of four.Source: Authors." "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Variable \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">With pre-extubation Rp Average (Range/ED) or frequency (%) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Without pre extubation Rp Average (Range/ED) or Frequency (%) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">p \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">With PACU Rp Average (Range/ED) or frequency (%) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Without PACU Rp Average (Range/ED) or frequency (%) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">p \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Age (years) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">73.5 (29) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">70 (32) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.132 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">72.5 (37) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">72 (24) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.833 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Gender (male) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">88 (81.5%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">87 (72.5%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.074 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">99 (91.7%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">108 (90%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.420 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Weight (kg) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">60 (42) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">63 (56) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.127 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">60 (56) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">65 (32) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.172 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">BMI (kg/m2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">24.50 (3.12) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">25.14 (3.8) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.267 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">24.61 (3.31) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">24.97 (3.21) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.636 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Comorbidities \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (4) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.574 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (4) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.737 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Prior TOF \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">100 (10) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">100 (13) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.092 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">100 (10) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">100 (13) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.251 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1115435.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Demographic data and TOF prior to exposure according to outcome." ] ] 2 => array:9 [ "identificador" => "tbl0015" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "fuente" => "Source: Authors." "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at3" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Variable \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Pre-extubation \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">PACU \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Residual relaxation \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">53 (23.2%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">21 (9.2%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="3" align="left" valign="top"></td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="3" align="left" valign="top">Severity</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Recovering \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">52 (88.1%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">21 (100%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Profound \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">1 (1.9%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 (0%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Profound and intense \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 (0.0%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 (0%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="3" align="left" valign="top"></td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="3" align="left" valign="top">Neuromuscular relaxant</td></tr><tr title="table-row"><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">p=0.001 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">p=0.728 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Rocuronium \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">29 (26.6%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">9 (8.3%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Cisatracurium \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">14 (14.3%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">9 (9.2%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Vecuronium \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">10 (52.6%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3 (15.8%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Pancuronium \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 (0%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 (0%) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1115436.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Residual relaxation." ] ] 3 => array:8 [ "identificador" => "tbl0020" "etiqueta" => "Table 4" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at4" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "a Estimated Latency of 68.42% of the data, n=156.Source: Authors." "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Variable \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Rocuronium \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Cisatracurium \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Vecuronium \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Pancuronium \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Dose \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0.52mg/kg(±0.14) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0.091mg/kg(±0.021) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0.858mg/kg(±0.033) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0.09mg/kg(±0.014) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ED95 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">25.7% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">49% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">26.3% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">50% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">74.3% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">51% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">73.7% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">50% \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Latenciaa \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2min(±6) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">6min(±9) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4min(±6) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1115438.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Neuromuscular relaxants (95ED: percentage use at a 95% effective dose," ] ] 4 => array:9 [ "identificador" => "tbl0025" "etiqueta" => "Table 5" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "fuente" => "Source: Authors." "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at5" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Clinical Criteria \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Pre-extubation \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Admission to the recovery room \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Raising head \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Sensitivity=18.75% PPV=64.29% Kappa=−0.073 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Sensitivity=14.29%, PPV=30%, Kappa=−0.022 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Presence of Apnea \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Sensitivity=12.5% PPV=37.5% Kappa=−0.031 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Sensitivity=0% PPV=0% Kappa=0.007 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Speaking smoothly \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Sensitivity=22.92% PPV.=37.93% Kappa=−0.06 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Sensitivity=4.76% PPV=6.25% Kappa=0.006 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Breathing smoothly \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Sensitivity=6.25% PPV=30% Kappa=−0.01 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Sensitivity=4.76% PPV=8.33% Kappa=0.002 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1115434.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Sensitivity, positive predictive value (PPV), and kappa coefficient for each Rp clinical criterion, based on the time of measurement." ] ] 5 => array:9 [ "identificador" => "tbl0030" "etiqueta" => "Table 6" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "fuente" => "Source: Authors." "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at6" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Variable \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Neostigmine+Atropine \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Sugammadex \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Pharmacological reversal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">17 (53.1%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">15 (46.9%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Dose \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0.04mg/kg (±0.02)+0.72mg(±0.24) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3.15mg/kg (±0.88) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Effectiveness \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">13 of 15 (88.24%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">15 of 15 (100%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Latency (p=0.522) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">5.07min (±2.58) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4.29min (±3.82) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1115437.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Reversal of residual paralysis." ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:20 [ 0 => array:3 [ "identificador" => "bib0105" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "B. Debaene" 1 => "B. Plaud" 2 => "M.P. Dilly" 3 => "F. Donati" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anesthesiology" "fecha" => "2003" "volumen" => "98" "paginaInicial" => "1042" "paginaFinal" => "1048" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12717123" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0110" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The undesirable effects of neuromuscular blocking drugs" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "C. Claudius" 1 => "L.H. Garvey" 2 => "J. Viby-Mogensen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2044.2008.05866.x" "Revista" => array:7 [ "tituloSerie" => "Anaesthesia" "fecha" => "2009" "volumen" => "64" "numero" => "Suppl 1" "paginaInicial" => "10" "paginaFinal" => "21" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19222427" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0115" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Residual paralysis after emergence from anesthesia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "B. Plaud" 1 => "B. Debaene" 2 => "F. Donati" 3 => "J. Marty" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/ALN.0b013e3181cded07" "Revista" => array:6 [ "tituloSerie" => "Anesthesiology" "fecha" => "2010" "volumen" => "112" "paginaInicial" => "1013" "paginaFinal" => "1022" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20234315" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0120" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Residual paralysis: a real problem or did we invent a new disease?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "F. Donati" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s12630-013-9932-8" "Revista" => array:7 [ "tituloSerie" => "Can J Anesth" "fecha" => "2013" "volumen" => "60" "paginaInicial" => "714" "paginaFinal" => "729" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23625545" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0049017210001782" "estado" => "S300" "issn" => "00490172" ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0125" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The RECITE study: a Canadian prospective multicenter study of the incidence and severity of residual neuromuscular blockade" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L.P. Fortier" 1 => "D. McKeen" 2 => "K. Turner" 3 => "É. de Médicis" 4 => "B. Warriner" 5 => "P.M. Jones" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1213/ANE.0000000000000757" "Revista" => array:6 [ "tituloSerie" => "Anesth Analg" "fecha" => "2015" "volumen" => "121" "paginaInicial" => "366" "paginaFinal" => "372" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25902322" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0130" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Residual paralysis at the time of tracheal extubation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "G.S. Murphy" 1 => "J.W. Szokol" 2 => "J.H. Marymont" 3 => "M. Franklin" 4 => "M.J. Avram" 5 => "J.S. Vender" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1213/01.ANE.0000151159.55655.CB" "Revista" => array:6 [ "tituloSerie" => "Anesth Analg" "fecha" => "2005" "volumen" => "100" "paginaInicial" => "1840" "paginaFinal" => "1845" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15920224" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0135" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A survey of current management of neuromuscular block in the United States and Europe" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M. Naguib" 1 => "A.F. Kopman" 2 => "C.A. Lien" 3 => "J.M. Hunter" 4 => "A. Lopez" 5 => "S.J. Brull" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1213/ANE.0b013e3181c07428" "Revista" => array:6 [ "tituloSerie" => "Anesth Analg" "fecha" => "2010" "volumen" => "111" "paginaInicial" => "110" "paginaFinal" => "119" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19910616" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0140" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A. Butterly" 1 => "E.A. Bittner" 2 => "E. George" 3 => "W.S. Sandberg" 4 => "M. Eikermann" 5 => "U. Schmidt" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/bja/aeq157" "Revista" => array:6 [ "tituloSerie" => "Br J Anaesth" "fecha" => "2010" "volumen" => "105" "paginaInicial" => "304" "paginaFinal" => "309" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20576632" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0145" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intraoperative neuromuscular monitoring site and residual paralysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "S.R. Thilen" 1 => "B.E. Hansen" 2 => "R. Ramaiah" 3 => "C.D. Kent" 4 => "M.M. Treggiari" 5 => "S.M. Bhananker" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/ALN.0b013e31826f8fdd" "Revista" => array:6 [ "tituloSerie" => "Anesthesiology" "fecha" => "2012" "volumen" => "117" "paginaInicial" => "964" "paginaFinal" => "972" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23001053" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0150" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Residual neuromuscular blockade affects postoperative pulmonary function" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "G.V. Kumar" 1 => "A.P. Nair" 2 => "H.S. Murthy" 3 => "K.R. Jalaja" 4 => "K. Ramachandra" 5 => "G. Parameshwara" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/ALN.0b013e3182715b80" "Revista" => array:6 [ "tituloSerie" => "Anesthesiology" "fecha" => "2012" "volumen" => "117" "paginaInicial" => "1234" "paginaFinal" => "1244" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23090145" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0155" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "G.S. Murphy" 1 => "S.J. Brull" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1213/ANE.0b013e3181da832d" "Revista" => array:7 [ "tituloSerie" => "Anesth Analg" "fecha" => "2010" "volumen" => "111" "paginaInicial" => "120" "paginaFinal" => "128" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20442260" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0140673604166762" "estado" => "S300" "issn" => "01406736" ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0160" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Residual neuromuscular block in elderly patients after surgical procedures under general anaesthesia with rocuronium" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "P. Pietraszewski" 1 => "T. Gaszynski" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.5603/AIT.2013.0017" "Revista" => array:6 [ "tituloSerie" => "Anaesthesiol Intensive Ther" "fecha" => "2013" "volumen" => "45" "paginaInicial" => "77" "paginaFinal" => "81" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23877899" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0165" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents. II: The Stockholm revision" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "T. Fuchs-Buder" 1 => "C. Claudius" 2 => "T. Skovgaard" 3 => "I. Eriksson" 4 => "K. Mirakhur" 5 => "J. Viby-Mergensen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1399-6576.2007.01352.x" "Revista" => array:6 [ "tituloSerie" => "Acta Anaesthesiol Scand" "fecha" => "2007" "volumen" => "51" "paginaInicial" => "789" "paginaFinal" => "808" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17635389" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0170" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Can acceleromyography detect low levels of residual paralysis? A probability approach to detect a mechanomyographic train-of-four ratio of 0.9" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "F. Capron" 1 => "F. Alla" 2 => "C. Hottier" 3 => "C. Meistelman" 4 => "T. Fuchs-Buder" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anesthesiology" "fecha" => "2004" "volumen" => "100" "paginaInicial" => "1119" "paginaFinal" => "1124" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15114208" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0175" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Monitoring neuromuscular block: an update" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "T. Fuchs-Buder" 1 => "J.U. Schreiber" 2 => "C. Meistelman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2044.2008.05874.x" "Revista" => array:7 [ "tituloSerie" => "Anaesthesia" "fecha" => "2009" "volumen" => "64" "numero" => "Suppl 1" "paginaInicial" => "82" "paginaFinal" => "89" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19222435" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0180" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Current recommendations for monitoring depth of neuromuscular blockade" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C.A. Lien" 1 => "A.F. Kopman" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Curr Opin Anesthesiol" "fecha" => "2014" "volumen" => "27" "paginaInicial" => "616" "paginaFinal" => "622" ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0185" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Variabilidad clínica del Vecuronio. Experienciaenunainstituciónen Colombia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "L. Reyes" 1 => "L. Muñoz" 2 => "D. Orozco" 3 => "C. Arias" 4 => "V. Vergel" 5 => "A. Valencia" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Colomb Anestesiol" "fecha" => "2012" "volumen" => "40" "paginaInicial" => "251" "paginaFinal" => "255" "itemHostRev" => array:3 [ "pii" => "S1699258X11001720" "estado" => "S300" "issn" => "1699258X" ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0190" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal video radiography and simultaneous manometry after atracurium" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "E. Sundman" 1 => "H. Witt" 2 => "R. Olsson" 3 => "O. Ekberg" 4 => "R. Kuylenstierna" 5 => "L.I. Eriksson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Anesthesiology" "fecha" => "2000" "volumen" => "92" "paginaInicial" => "977" "paginaFinal" => "984" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10754616" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0195" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Postoperative residual neuromuscular block: a survey of management" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Baillard" 1 => "C. Clećh" 2 => "J. Catineau" 3 => "F. Salhi" 4 => "G. Gehan" 5 => "M. Cupa" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/bja/aei240" "Revista" => array:6 [ "tituloSerie" => "Br J Anaesth" "fecha" => "2005" "volumen" => "95" "paginaInicial" => "622" "paginaFinal" => "626" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16183681" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0200" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sugammadex en paciente neonatal" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "V.H. González" 1 => "F. Munar" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rev Colomb Anestesiol" "fecha" => "2013" "volumen" => "41" "paginaInicial" => "171" "paginaFinal" => "174" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/22562087/0000004400000003/v1_201607020109/S2256208716300244/v1_201607020109/en/main.assets" "Apartado" => array:4 [ "identificador" => "951" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Scientific and Technological Research" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/22562087/0000004400000003/v1_201607020109/S2256208716300244/v1_201607020109/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2256208716300244?idApp=UINPBA00004N"]

Statistics

Scientific and Technological Research

Relajación residual postoperatoria en pacientes mayores de 65 años en la Unidad de Cuidado Posanestésico

Víctor Hugo González-Cárdenasa,c,

Corresponding author

vhgonzalez@fucsalud.edu.co

Corresponding author at: Fundación Hospital Infantil Universitario de San José, Oficina de Anestesiología, Carrera 52 # 67 A 71, Cuarto Piso, Bogotá, Colombia.

, Kelly Johana Salazar-Ramírezb,c, Gina Tatiana Coral-Sánchezb,c

a MD, Anesthesiologist, Clinical Epidemiologist, Associated Professor at the Fundación Universitaria de las Ciencias de la Salud (FUCS), and Universidad de La Sabana, Fundación Hospital Infantil Universitario de San José, Bogotá D. C., Colombia, Bogotá D.C., Colombia

b MD, Anesthesiologist Resident, Universidad de La Sabana, Chía, Colombia

c Research Groups in Anesthesia Deorum Opus - Fundación Universitaria de Ciencias de la Salud / Fundación Hospital Infantil Universitario de San José / and Mandrágora, Hospital Universitario de la Samaritana

Read

2168

Times
was read the article

552

Total PDF

1616

Total HTML

Share statistics

 array:24 [
  "pii" => "S2256208716300244"
  "issn" => "22562087"
  "doi" => "10.1016/j.rcae.2016.04.008"
  "estado" => "S300"
  "fechaPublicacion" => "2016-07-01"
  "aid" => "289"
  "copyrightAnyo" => "2016"
  "documento" => "article"
  "crossmark" => 1
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Rev Colomb Anestesiol. 2016;44:209-15"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1015
    "formatos" => array:3 [
      "EPUB" => 96
      "HTML" => 687
      "PDF" => 232
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:20 [
      "pii" => "S0120334716300405"
      "issn" => "01203347"
      "doi" => "10.1016/j.rca.2016.04.006"
      "estado" => "S300"
      "fechaPublicacion" => "2016-07-01"
      "aid" => "289"
      "copyright" => "Sociedad Colombiana de Anestesiolog&#237;a y Reanimaci&#243;n"
      "documento" => "article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "fla"
      "cita" => "Rev Colomb Anestesiol. 2016;44:211-7"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 4563
        "formatos" => array:3 [
          "EPUB" => 92
          "HTML" => 3730
          "PDF" => 741
        ]
      ]
      "es" => array:12 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Investigaci&#243;n cient&#237;fica y tecnol&#243;gica</span>"
        "titulo" => "Relajaci&#243;n residual postoperatoria en pacientes mayores de 65 a&#241;os en la Unidad de Cuidado Postanest&#233;sico"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "211"
            "paginaFinal" => "217"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Postoperative residual paralysis in patients aged over 65 years old at the Post-Anesthesia Care Unit"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "V&#237;ctor Hugo Gonz&#225;lez-C&#225;rdenas, Kelly Johana Salazar-Ram&#237;rez, Gina Tatiana Coral-S&#225;nchez"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "V&#237;ctor Hugo"
                "apellidos" => "Gonz&#225;lez-C&#225;rdenas"
              ]
              1 => array:2 [
                "nombre" => "Kelly Johana"
                "apellidos" => "Salazar-Ram&#237;rez"
              ]
              2 => array:2 [
                "nombre" => "Gina Tatiana"
                "apellidos" => "Coral-S&#225;nchez"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2256208716300244"
          "doi" => "10.1016/j.rcae.2016.04.008"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2256208716300244?idApp=UINPBA00004N"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0120334716300405?idApp=UINPBA00004N"
      "url" => "/01203347/0000004400000003/v2_201607220246/S0120334716300405/v2_201607220246/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S2256208716300219"
    "issn" => "22562087"
    "doi" => "10.1016/j.rcae.2016.04.005"
    "estado" => "S300"
    "fechaPublicacion" => "2016-07-01"
    "aid" => "285"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Rev Colomb Anestesiol. 2016;44:216-21"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 984
      "formatos" => array:3 [
        "EPUB" => 95
        "HTML" => 652
        "PDF" => 237
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Scientific and Technological Research</span>"
      "titulo" => "Transcultural and linguistic adaptation of the Richmond Agitation-Sedation Scale to Spanish"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "216"
          "paginaFinal" => "221"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Validaci&#243;n transcultural y ling&#252;&#237;stica de la escala de sedaci&#243;n y agitaci&#243;n Richmond al espa&#241;ol"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:9 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "fuente" => "<span class="elsevierStyleItalic">Source</span>&#58; Authors&#46;"
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1240
              "Ancho" => 1652
              "Tamanyo" => 56667
            ]
          ]
          "detalles" => array:1 [
            0 => array:3 [
              "identificador" => "at1"
              "detalle" => "Table "
              "rol" => "short"
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Absolute frequency for each grade using the Spanish version of RASS in 300 evaluations performed&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Jos&#233; Antonio Rojas-Gambasica, Albert Valencia-Moreno, V&#237;ctor Hugo Nieto-Estrada, Pablo M&#233;ndez-Osorio, Daniel Molano-Franco, &#193;lvaro Tito Jim&#233;nez-Quimbaya, Ra&#250;l Escobar-Modesto, Nayibe Cort&#233;s-Rodr&#237;guez, Liliana Paola Correa"
          "autores" => array:9 [
            0 => array:2 [
              "nombre" => "Jos&#233; Antonio"
              "apellidos" => "Rojas-Gambasica"
            ]
            1 => array:2 [
              "nombre" => "Albert"
              "apellidos" => "Valencia-Moreno"
            ]
            2 => array:2 [
              "nombre" => "V&#237;ctor Hugo"
              "apellidos" => "Nieto-Estrada"
            ]
            3 => array:2 [
              "nombre" => "Pablo"
              "apellidos" => "M&#233;ndez-Osorio"
            ]
            4 => array:2 [
              "nombre" => "Daniel"
              "apellidos" => "Molano-Franco"
            ]
            5 => array:2 [
              "nombre" => "&#193;lvaro Tito"
              "apellidos" => "Jim&#233;nez-Quimbaya"
            ]
            6 => array:2 [
              "nombre" => "Ra&#250;l"
              "apellidos" => "Escobar-Modesto"
            ]
            7 => array:2 [
              "nombre" => "Nayibe"
              "apellidos" => "Cort&#233;s-Rodr&#237;guez"
            ]
            8 => array:2 [
              "nombre" => "Liliana Paola"
              "apellidos" => "Correa"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0120334716300326"
        "doi" => "10.1016/j.rca.2016.04.003"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0120334716300326?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2256208716300219?idApp=UINPBA00004N"
    "url" => "/22562087/0000004400000003/v1_201607020109/S2256208716300219/v1_201607020109/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2256208716300268"
    "issn" => "22562087"
    "doi" => "10.1016/j.rcae.2016.05.002"
    "estado" => "S300"
    "fechaPublicacion" => "2016-07-01"
    "aid" => "291"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Rev Colomb Anestesiol. 2016;44:201-8"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1049
      "formatos" => array:3 [
        "EPUB" => 106
        "HTML" => 705
        "PDF" => 238
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Scientific and Technological Research</span>"
      "titulo" => "Characterization and analysis of adverse events in closed liability cases involving anaesthetists who received legal support from the Colombian Society of Anaesthesia and Resuscitation &#40;S&#46;C&#46;A&#46;R&#46;E&#46;&#41;&#44; Colombia&#44; 1993&#8211;2012"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "201"
          "paginaFinal" => "208"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Caracterizaci&#243;n y an&#225;lisis de eventos adversos en procesos cerrados de anestesi&#243;logos apoderados por la Sociedad Colombiana de Anestesiolog&#237;a y Reanimaci&#243;n &#40;S&#46;C&#46;A&#46;R&#46;E&#46;&#41; en Colombia entre 1993&#8211;2012"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:9 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "fuente" => "<span class="elsevierStyleItalic">Source</span>&#58; the authors&#46;"
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1440
              "Ancho" => 1587
              "Tamanyo" => 96458
            ]
          ]
          "detalles" => array:1 [
            0 => array:3 [
              "identificador" => "at1"
              "detalle" => "Table "
              "rol" => "short"
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Case selection for the analysis&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Juan Carlos Bocanegra-Rivera, Jos&#233; Hugo Arias-Botero"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "Juan Carlos"
              "apellidos" => "Bocanegra-Rivera"
            ]
            1 => array:2 [
              "nombre" => "Jos&#233; Hugo"
              "apellidos" => "Arias-Botero"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0120334716300454"
        "doi" => "10.1016/j.rca.2016.04.008"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0120334716300454?idApp=UINPBA00004N"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2256208716300268?idApp=UINPBA00004N"
    "url" => "/22562087/0000004400000003/v1_201607020109/S2256208716300268/v1_201607020109/en/main.assets"
  ]
  "en" => array:19 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Scientific and Technological Research</span>"
    "titulo" => "Postoperative residual paralysis in patients aged over 65 years old at the Post-Anesthesia Care Unit"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "209"
        "paginaFinal" => "215"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "V&#237;ctor Hugo Gonz&#225;lez-C&#225;rdenas, Kelly Johana Salazar-Ram&#237;rez, Gina Tatiana Coral-S&#225;nchez"
        "autores" => array:3 [
          0 => array:4 [
            "nombre" => "V&#237;ctor Hugo"
            "apellidos" => "Gonz&#225;lez-C&#225;rdenas"
            "email" => array:1 [
              0 => "vhgonzalez&#64;fucsalud&#46;edu&#46;co"
            ]
            "referencia" => array:3 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0020"
              ]
              2 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Kelly Johana"
            "apellidos" => "Salazar-Ram&#237;rez"
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0015"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0020"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Gina Tatiana"
            "apellidos" => "Coral-S&#225;nchez"
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0015"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0020"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "MD&#44; Anesthesiologist&#44; Clinical Epidemiologist&#44; Associated Professor at the Fundaci&#243;n Universitaria de las Ciencias de la Salud &#40;FUCS&#41;&#44; and Universidad de La Sabana&#44; Fundaci&#243;n Hospital Infantil Universitario de San Jos&#233;&#44; Bogot&#225; D&#46; C&#46;&#44; Colombia&#44; Bogot&#225; D&#46;C&#46;&#44; Colombia"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "MD&#44; Anesthesiologist Resident&#44; Universidad de La Sabana&#44; Ch&#237;a&#44; Colombia"
            "etiqueta" => "b"
            "identificador" => "aff0015"
          ]
          2 => array:3 [
            "entidad" => "Research Groups in Anesthesia Deorum Opus - Fundaci&#243;n Universitaria de Ciencias de la Salud &#47; Fundaci&#243;n Hospital Infantil Universitario de San Jos&#233; &#47; and Mandr&#225;gora&#44; Hospital Universitario de la Samaritana"
            "etiqueta" => "c"
            "identificador" => "aff0020"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author at</span>&#58; Fundaci&#243;n Hospital Infantil Universitario de San Jos&#233;&#44; Oficina de Anestesiolog&#237;a&#44; Carrera 52 &#35; 67 A 71&#44; Cuarto Piso&#44; Bogot&#225;&#44; Colombia&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Relajaci&#243;n residual postoperatoria en pacientes mayores de 65 a&#241;os en la Unidad de Cuidado Posanest&#233;sico"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Neuromuscular relaxation is mainly used to facilitate orotracheal intubation&#44; for improved visualization and manipulation of the surgical field&#44; and to optimize the patient&#8211;ventilator interaction when appropriate&#46;<a class="elsevierStyleCrossRefs" href="#bib0105"><span class="elsevierStyleSup">1&#44;2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Notwithstanding the considerable benefits of these drugs&#44; they may lead to post-operative residual paralysis &#40;Rp&#41;&#46;<a class="elsevierStyleCrossRefs" href="#bib0105"><span class="elsevierStyleSup">1&#8211;3</span></a> The recommendation is to make the diagnosis using quantitative criteria to assess the function of the neuromuscular junction through peripheral nerve stimulation that guides our choice of a safe neuromuscular relaxation therapy and helps to optimize the pharmacological reversal measures&#46;<a class="elsevierStyleCrossRefs" href="#bib0105"><span class="elsevierStyleSup">1&#8211;3</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">According to the study&#44; the incidence of residual paralysis ranges from 2&#37; to 88&#37;&#46;<a class="elsevierStyleCrossRefs" href="#bib0105"><span class="elsevierStyleSup">1&#44;4&#44;5</span></a> In the opinion of Donati&#44;<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">4</span></a> this number is closer to 57&#37;&#44; averaging the results from the trials by Murphy&#44; Naguib&#44; Kumar&#44; Butterly and Thilen&#44; reported between 2007 and 2012&#46; It should be stressed however&#44; that based on this study&#44; only 1&#37; of anesthetists actually consider the problem&#46;<a class="elsevierStyleCrossRefs" href="#bib0130"><span class="elsevierStyleSup">6&#8211;10</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">Residual paralysis is relevant because it may go unnoticed during the post-anesthesia recovery period&#44; giving rise to severe respiratory post-operative complications associated with longer extubation times&#44; risk of re-intubation&#44; bronchoaspiration&#44; extended recovery&#44; delayed PACU discharge&#44; and even more severe life-threatening conditions&#46;<a class="elsevierStyleCrossRefs" href="#bib0105"><span class="elsevierStyleSup">1&#44;3&#44;5&#8211;7&#44;11</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">There is a wide range of studies worldwide but usually they fail to consider the population over 65 years of age&#46; These so-called &#8220;elderly&#8221; patients usually present an impaired organ ability to clear medications and increased sensitivity in terms of length and depth of the relaxation effects that may result in additional economic and healthcare burden&#46;<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">12</span></a> In fact&#44; the Polish trial by Pietraszewski et al&#46;&#44;<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">12</span></a> describes the higher Rp incidence in patients aged 65 through 89&#44; in contrast with patients between 19 and 57 years old &#40;44&#37; vs&#46; 20&#37;&#41;&#44; and even higher rates of hypoxia when comparing both groups &#40;17&#46;9&#37; vs&#46; 8&#46;2&#37;&#41;&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">The incidence of Residual Paralysis is yet unknown&#44; particularly when referring to people over 65 years of age&#44; since the statistics reported for this age group are meager&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">Based on the above statements and considering the major impact of evaluating both the incidence and current management of Rp in patients over 65 years old&#44; we tried to respond the following question&#58; &#8220;What is the incidence of Rp in patients over 65 years of age&#44; exposed to nondepolarizing neuromuscular relaxants&#63; Which are the characteristics of the current treatment for residual paralysis in patients aged 65 and older&#63;</p><p id="par0040" class="elsevierStylePara elsevierViewall">The key objective in trying to answer these questions was to estimate the incidence of Rp in patients over 65 years old&#44; exposed to nondepolarizing relaxants&#44; and then to discuss the effectiveness of pharmacological reversal therapy&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Materials and methods</span><p id="par0045" class="elsevierStylePara elsevierViewall">Analytical&#44; observational&#44; cohort-based trial at the Samaritana University Hospital and the San Jose University Children&#39;s Hospital Foundation&#44; between 2014 and 2015&#46; The cohort inclusion criteria included&#58; patients over 65 years old exposed to nondepolarizing neuromuscular relaxants&#46; All patients discharged from the ICU with mechanical ventilation were excluded&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">The patients enrolled in the trial were conveniently selected in consecutive order based on the surgical schedule of the research institution&#46; Only the records that met the selection criteria and were fully compliant with the Stockholm Consensus were included in the analysis&#46;<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">13</span></a></p><p id="par0055" class="elsevierStylePara elsevierViewall">Residual paralysis was defined as a train of four &#40;TOF&#41; ratio between the first and the last motor response &#40;T4&#47;T1&#41; of less than 90&#37;&#46; This measurement was taken according to the parameters under the Stockholm Consensus<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">13</span></a> using two different approaches&#58; TOF-Watch SX &#40;TOF-Watch XS Device&#44; Organon&#44; Oss&#44; The Netherlands&#41;&#46; Single-use disposable electrodes were placed over the skin on the cubital nerve after cleaning thoroughly a 2&#8211;3<span class="elsevierStyleHsp" style=""></span>cm<span class="elsevierStyleSup">2</span> surface&#46; The accelerometer was placed on the pulp of the first digit making sure that the hand movement was artifact-free for an unbiased accelerometer reading&#46; A measurement was taken at the time of admission to the OR&#44; at the end of surgery&#44; prior to extubation&#44; and when the patient was admitted to the recovery room&#46; In case of reversal of the residual paralysis&#44; the necessary TOF measurements were taken from the time of the initial administration of the agent&#44; until a value of over 90&#37; was obtained&#46; This period of time was the time required for total reversal of the residual paralysis&#46; It is important to highlight that the arm used for taking the measurements was immobilized during the measurements and the medications used were administered via a separate line&#46; The measurements were taken by one of the three principal researchers participating in the trial and were masked and independent from medical care&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall">The clinical predictors for residual paralysis were evaluated at two different times&#58; pre-extubation and at the time of admission to the recovery room&#46; Some of the tests administered included the ability to hold the head up for more than five seconds&#44; the presence of apnea&#44; compliance with the ventilation extubation criteria&#44; and the ability to speak easily&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall">Our primary objective was to measure the incidence of residual paralysis in the OR prior to extubation and at the time of admission to the recovery unit&#44; in addition to evaluating the severity of the residual paralysis in association with clinical signs measurements for the recovery of the neuromuscular junction&#46; In every case any residual paralysis-related complications were mentioned&#44; in addition to the pharmacological reversal&#44; including the need to admit the patient to the ICU&#46;</p><p id="par0070" class="elsevierStylePara elsevierViewall">Based on the world literature&#44; we estimated that 228 records had to be assessed in order to obtain a 51&#46;5&#37; likelihood of Rp&#44; with a 95&#37; CI and a 6&#46;5&#37; accuracy&#46;</p><p id="par0075" class="elsevierStylePara elsevierViewall">The data recorded included demographics &#40;age&#44; gender&#44; body weight&#44; height&#41;&#44; pre-surgical information &#40;comorbidities&#44; use of pre-anesthesia drugs&#44; surgical diagnosis&#44; and intra-operative variables such as IV anesthetic agents&#44; inhaled anesthesia&#44; antibiotics&#44; GI protective agents&#44; antiemetics&#44; and divalent electrolytes&#44; in addition to the neuromuscular relaxants studied at full and body weight estimated doses&#41;&#46;</p><p id="par0080" class="elsevierStylePara elsevierViewall">The TOF and TOF-T4&#47;T1 protocol measurements were recorded and the latency time required for a value of less than 25&#37; was measured&#46; Similarly&#44; the relaxation strategy &#40;infusion or bolus&#41;&#44; the need for additional doses&#44; the time elapsed from the first to the last dose prior to extubation&#44; were all analyzed&#46; The clinical predictors for Rp were also considered and their concordance was evaluated using Kappas&#46; Moreover&#44; accuracy &#40;sensitivity and specificity&#41; and behavioral &#40;positive and negative predictive value&#41; tests were estimated&#44; versus the TOF-based Rp diagnosis&#46;</p><p id="par0085" class="elsevierStylePara elsevierViewall">When reversal of the residual paralysis was used&#44; a record was made of the pharmacological strategy used by the physician responsible for the patient in the recovery room or the OR&#44; including the dose and recovery times&#46; Any reversal-associated complications were monitored for at least 2<span class="elsevierStyleHsp" style=""></span>h by one of the three principal researchers participating in this trial&#46;</p><p id="par0090" class="elsevierStylePara elsevierViewall">The additional confounding variables included trans-operative crystalloid volume in mL&#44; trans-operative temperature and TOF measurements during residual paralysis reversal&#46;</p><p id="par0095" class="elsevierStylePara elsevierViewall">The quantitative statistics were presented according to their respective area&#44; using central trend measurements &#40;median or mean values&#41; and scatter &#40;ranges or standard deviation&#41; depending on their distribution&#59; the qualitative variables were presented in absolute frequencies and percentages&#46; The various hypotheses were compared based on the statistical requirements&#44; using the Ji<span class="elsevierStyleSup">2</span> test to compare qualitative variables and Student-<span class="elsevierStyleItalic">T</span> test or <span class="elsevierStyleItalic">U</span> Mann&#8211;Whitney for quantitative variables&#46; When required&#44; the impacts and the 95&#37; CI were estimated&#46; The correlation coefficients were evaluated for ordinal data using RHO Spearman and statistical significance&#46; The <span class="elsevierStyleItalic">R</span><span class="elsevierStyleSup">2</span> was measured and reported as needed&#46; The statistical significance was based on <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;05&#44; and the statistical package used for data processing was STATA 12&#46;0&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Results</span><p id="par0100" class="elsevierStylePara elsevierViewall">Prior authorization of the Technical Committee and of the Ethics Committee for research on human beings of the Samaritana University Hospital and the San Jose University Children&#39;s Hospital Foundation&#44; in addition to the Research Sub-commission of the School of Medicine of the Sabana University&#44; 228 complete records that met the selection criteria were included in the analysis&#59; these are listed in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0105" class="elsevierStylePara elsevierViewall">When describing the demographics of the patients with Rp prior to extubation and admission to the recovery room&#44; vs&#46; those with no residual relaxation&#44; no statistically significant differences were identified between the two groups &#40;<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>&#41;&#46;</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0110" class="elsevierStylePara elsevierViewall">The incidence of residual paralysis in each situation and its intensity are described in <a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>&#44; together with the stratified Rp incidences for each neuromuscular relaxant used&#46; <a class="elsevierStyleCrossRef" href="#tbl0020">Table 4</a> illustrates the mean dose of each relaxant used&#44; the percentage use with a 95 ED and the percentage of use at doses slightly below 95 ED&#46; Additionally&#44; the latency measured under the protocol parameters is shown for 156 valid records&#46;</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><elsevierMultimedia ident="tbl0020"></elsevierMultimedia><p id="par0115" class="elsevierStylePara elsevierViewall">The clinical evaluation of Rp showed a very poor correlation between the TOF value and the presence of clinical predictors for Rp&#46; When evaluating based on Searman Rho coefficient&#44; clinical pre-extubation criteria and the presence of Rp diagnosed by TOF the result was Rho<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;137&#44; while in terms of the presence of clinical criteria at admission to the recovery room and the presence of Rp diagnosed by TOF the Rho<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>&#8722;0&#46;052&#46; Furthermore&#44; when evaluating the accuracy and the behavior of each individual criterion both at the time of pre-extubation and at admission to the recovery room&#44; we evidenced poor diagnostic accuracy in each case &#40;<a class="elsevierStyleCrossRef" href="#tbl0025">Table 5</a> shows the sensitivities&#44; the PPV &#40;positive predictive value&#41;&#44; and the Kappa coefficients for each test&#41;&#46;</p><elsevierMultimedia ident="tbl0025"></elsevierMultimedia><p id="par0120" class="elsevierStylePara elsevierViewall">Additionally&#44; prior to extubation the following Kappa coefficients were estimated&#58; raising head &#40;&#8722;0&#46;073&#41;&#44; apnea &#40;&#8722;0&#46;031&#41;&#44; speaking &#40;&#8722;0&#46;06&#41;&#44; and ability to ventilate properly &#40;&#8722;0&#46;01&#41;&#46; At admission to the recovery room&#44; the following Kappa coefficients were estimated&#58; raising head &#40;&#8722;0&#46;022&#41;&#44; apnea &#40;0&#46;007&#41;&#44; speaking &#40;0&#46;006&#41;&#44; and ability to ventilate properly &#40;0&#46;002&#41;&#46;</p><p id="par0125" class="elsevierStylePara elsevierViewall">Finally&#44; the use of each pharmacological reversal therapy&#44; their mean doses&#44; effectiveness achieved&#44; and latency minutes required for satisfactory reversal in each group were specified &#40;<a class="elsevierStyleCrossRef" href="#tbl0030">Table 6</a>&#41;&#46;</p><elsevierMultimedia ident="tbl0030"></elsevierMultimedia></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Discussion</span><p id="par0130" class="elsevierStylePara elsevierViewall">The study of post-operative residual paralysis &#40;Rp&#41; has become increasingly relevant during the past decade&#59; the growing use of neuromuscular junction function monitors and the publication of several studies stressing the importance thereof&#44; have given rise to a broad diagnostic spectrum for preventing Rr-associated post-operative complications&#46;<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">4</span></a></p><p id="par0135" class="elsevierStylePara elsevierViewall">The information on the incidence of residual relaxation and its associated factors prior to the advent of neurostimulation lacked a strong analytic foundation to establish direct causality&#46; After the introduction of relaxation monitoring with TOF in the 1970s&#44; the incidence of Rp apparently declined&#44; and although the analytic methods measuring TOF gained validity&#44; the considerably varying incidences identified by different authors have failed to provide global and reliable data applicable to all populations&#46;</p><p id="par0140" class="elsevierStylePara elsevierViewall">Three different techniques may be used to monitor the neuromuscular junction&#58; electromyography&#44; mechanomyography&#44; and acceleromyography&#46; The latter is the foundation for modern anesthesia monitoring which is convenient&#44; economic&#44; and highly correlated with other more sensitive evaluation approaches such as the results from mechanomyography&#46;<a class="elsevierStyleCrossRefs" href="#bib0115"><span class="elsevierStyleSup">3&#44;11&#44;14&#44;15</span></a> It is important to state that the method used in our trial was acceleromyography&#44; since this is the standard measurement method in the OR&#46;</p><p id="par0145" class="elsevierStylePara elsevierViewall">Multiple studies have shown that qualitative monitoring is not associated with quantitative measurements&#46; In fact&#44; the latter have been described as measurements that are independent from the clinical signs of complete neuromuscular relaxation&#46; In our study we found no correlation between TOF monitoring and the clinical criteria often used in anesthesiology to predict adequate performance of the junction at the end of surgery &#40;RHO Spearman<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;137&#41;&#44; and the same parameters with regards to the TOF value measured at the time of admission to the recovery room &#40;RHO Spearman<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>&#8722;0&#46;052&#41;&#46; These are proven facts of very poor sensitivities&#44; PPV and Kappa for every clinical predictor&#46; &#40;See <a class="elsevierStyleCrossRef" href="#tbl0030">Table 6</a>&#41;&#46;</p><p id="par0150" class="elsevierStylePara elsevierViewall">In terms of the patients enrolled in this analysis&#44; the incidence of residual paralysis prior to extubation was 23&#46;2&#37;&#44; and 9&#46;2&#37; at the time admission to the recovery room&#46; These values are lower than those measured by Fortier et al&#46;<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">5</span></a> &#40;Metaanalysis &#8211; 2015&#41;&#59; in this case the incidence of residual paralysis was 63&#46;5&#37; prior to extubation and 56&#46;5&#37; at the time of admission to the recovery room&#46;</p><p id="par0155" class="elsevierStylePara elsevierViewall">Debaene et al&#46;<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">1</span></a> determined the percentage of residual paralysis in the recovery room&#44; and found that the incidence of patients with TOF<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;9 &#40;acceleromyography&#41; following a single dose of intubation &#40;equivalent to two effective 95 doses&#44; ED95&#41; at the tie of admission to the recovery room was 45&#37;&#44; and 37&#37; 2<span class="elsevierStyleHsp" style=""></span>h later &#40;in the same unit&#41;&#46;</p><p id="par0160" class="elsevierStylePara elsevierViewall">Murphy et al&#46;&#44; based on clinical and acceleromyography criteria&#44; estimated the residual paralysis at 88&#37; of the patients prior to extubation or immediately after extubation and 32&#37; of these patients in the recovery room with TOF<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;9&#44; despite meeting the clinical criteria&#46;</p><p id="par0165" class="elsevierStylePara elsevierViewall">It is striking that none of the trials considered to be of clinical value and previously referred to in this discussion&#44; weigh the severity of the paralysis measured before extubation and that measured in the recovery room&#46; In our records based on the classification published in 2014 by Lien and Kopman<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">16</span></a> and in 2007 by Fuchs-Buder et al&#46;<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">13</span></a>&#44; we classified the Rp into intense &#40;no response even following a tetanic impulse&#41;&#59; profound &#40;TOF<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>1 but with post tetanic Twitch response&#41;&#59; moderate &#40;TOF between 1 and 3&#41;&#59; and recovering &#40;any TOF-T4&#47;T1 value&#41;&#46; So in our patients in the OR prior to extubation&#44; only 1&#46;9&#37; were classified as moderate and the remaining 98&#46;1&#37; recovering&#44; whilst in the recovery room 100&#37; of the patients had a TOF<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>3 &#40;indicative of recovering&#41;&#46;</p><p id="par0170" class="elsevierStylePara elsevierViewall">When analyzing the booster doses for adequate intraoperative relaxation and the cases of Rp prior to extubation and recovery room&#44; no statistically significant differences were identified for either scenario &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;29 prior to extubation and <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;16 in the recovery room&#41;&#46; Apparently&#44; the impact of these booster doses was not necessarily associated with an increased Rp frequency&#46; The time elapsed since the last dose did not show a significant correlation when compared against the TOF values prior to extubation and at admission to the recovery room &#40;RHO Spearman<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;184 and 0&#46;187 respectively&#41;&#46; These findings suggest that the time between the last dose and the quantitative TOF-T4&#47;T1 value are not associated but are independent when weighing the risk of Rr in our patients&#46;</p><p id="par0175" class="elsevierStylePara elsevierViewall">An important consideration is that in our setting&#44; despite the frequent use of nondepolarizing neuromuscular relaxants&#44; a protocol is not followed and exclusively depends on the anesthetist&#39;s skill&#46; However&#44; it should be kept in mind that practically in every case the dose in these patients did not exceed the level indicated for intubation &#40;twoED95&#41;&#59; on the contrary&#44; it was even slightly lower than the estimated level &#40;see <a class="elsevierStyleCrossRef" href="#tbl0020">Table 4</a>&#41;&#46;</p><p id="par0180" class="elsevierStylePara elsevierViewall">When evaluating the NMR used by subgroup&#44; the incidence of pre-extubation Rp was 26&#46;6&#37; for Rocuronium&#59; 14&#46;3&#37; for Cisatracurium&#59; and 52&#46;6&#37; for Vecuronium&#44; differing significantly from one-another &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41;&#46; In contrast&#44; the incidence of Rp in the recovery room was of 8&#46;3&#37; for Rocuronium&#59; 9&#46;2&#37; for Cisatracurium&#59; and 15&#46;8&#37; for Vecuronium&#59; these differences however are not statistically significant &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;728&#41;&#46;</p><p id="par0185" class="elsevierStylePara elsevierViewall">When contrasting the incidences with Rocuronium versus Cisatracurium&#44; at the time of extubation we found that the values were significantly different &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;022&#41;&#59; a similar situation occurred when comparing the incidence of Rp with Cisatracurium and Vecuronium &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;001&#41;&#46; Apparently the incidence of Rp with Cisatracurium is more beneficial for patients than with the other agents&#46; While we may suggest that Cisatracurium was associated with a lower number of patients with Rp&#44; we cannot conclude that the quality or the depth of relaxation during surgery were superior since that appreciation was beyond the scope of our study but these outcomes are indeed relevant when deciding which agent should be used&#46;</p><p id="par0190" class="elsevierStylePara elsevierViewall">The Colombian regulations governed by INVIMA ensure the equivalence of the molecules and apparently similar efficacy for our population&#46; However&#44; it should be mentioned that different brand names for each pharmaceutical product were used in this trial&#44; except for Sugammadex&#59; this fact may contribute to the difference in the values reported in the world literature that questions the pharmacokinetics of generics versus original products&#46; Consequently&#44; the results from our research&#44; in addition to being novel&#44; may represent evidence of a potential non-variation in the expected results for our patients&#44; and are different from the outcomes reported by the pharmaceutical companies&#46; This may attest to the clinical similarity of the various molecules regardless of their origin&#44; production&#44; or manufacturing methods&#44; endorsing the technical opinion initially stated and consistent with the publications for other researchers such as Reyes et al&#46;<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">17</span></a>&#46;</p><p id="par0195" class="elsevierStylePara elsevierViewall">Different complications from residual relaxation due to poor airway protection&#44; declining response to hypoxia&#44; upper airway obstruction and decompensation of the genio-glossus muscle have been identified&#59; this is all associated with extended intubation&#44; risk of re-intubation&#44; or bronchoaspiration&#44; delayed recovery&#44; and delayed discharge from the recovery room&#44; inter alia&#46;<a class="elsevierStyleCrossRefs" href="#bib0125"><span class="elsevierStyleSup">5&#8211;7&#44;3&#44;18</span></a> In this trial&#44; notwithstanding the large number of patients who presented Rp in the recovery room&#44; only one of them experienced a complication &#40;laryngospasm&#41; that represented 4&#46;76&#37; of the cases&#44; but was not associated to any other outcomes or ICU requirements&#46;</p><p id="par0200" class="elsevierStylePara elsevierViewall">In order to prevent all these complications in clinical practice&#44; we have medications available that can revert any residual paralysis&#46; The most commonly used at the national level are the acetylcholinesterase inhibitors &#40;Neostigmina&#41; and Sugammadex&#46;</p><p id="par0205" class="elsevierStylePara elsevierViewall">The decision to administer one or the other is based on the severity of the Rp&#46; The current literature states that the principal disadvantage of Neostigmine is its failure to effectively treat intensive and profound residual relaxation&#59; this is contrary to the results reported with Sugammadex&#44; of proven efficacy for any Rp condition&#44; regardless of intensity&#44; but with a higher cost and no proven effect over the benzilisoquinolone-like nondepolarizing relaxants such as Cisatracurium&#46;<a class="elsevierStyleCrossRefs" href="#bib0120"><span class="elsevierStyleSup">4&#44;19</span></a></p><p id="par0210" class="elsevierStylePara elsevierViewall">In our study&#44; the decision to reverse the residual paralysis was made individually by each anesthetist&#59; the efficacy evaluation of the strategy used was 89&#46;4&#37; success rate in patients treated with Neostigmine plus Atropine&#44; and of 100&#37; in patients treated with Sugammadex&#46; For Neostigmine and Atropine&#44; the mean recovery time to T4&#47;T1<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>90&#37; was 5&#46;07<span class="elsevierStyleHsp" style=""></span>min &#40;ED<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>2&#46;58<span class="elsevierStyleHsp" style=""></span>min&#41; while for Sugammadex was 4&#46;29<span class="elsevierStyleHsp" style=""></span>min &#40;ED<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>3&#46;82<span class="elsevierStyleHsp" style=""></span>min&#41;&#46; The differences were not statistically significant &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;522&#41;&#44; and we feel there of no clinical relevance&#46; However&#44; one of our patients experienced a waiting time to achieve TOF<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>0&#46;9 with Sugammadex of 17<span class="elsevierStyleHsp" style=""></span>min&#46; In the light of our current knowledge this event is beyond our understanding&#44; despite the good clinical practices and pharmacovigilance of the institution where the event happened&#46;</p><p id="par0215" class="elsevierStylePara elsevierViewall">Although nausea and vomiting have been consistently reported immediately after the administration of Neostigmine and Atropine&#44; only one patient in the trial experienced this side effect&#44; which could be associated not just with exposure to the agent&#44; but with multiple other uncontrolled factors&#46; It is important to note that in contrast to other publications on the subject&#44; none of our patients experienced any hemodynamic complications or arrhythmias requiring further intervention&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Conclusions</span><p id="par0220" class="elsevierStylePara elsevierViewall">The incidence of residual paralysis associated with nondepolarizing neuromuscular relaxants in patients over 65 years old&#44; prior extubation and admission to the Recovery Room was below the number reported worldwide&#46; Residual paralysis reversal was equally effective when comparing Neostigmine versus Sugammadex&#44; with the latter exhibiting a 10&#37; higher clinical latency&#46; We do not discuss any side effects requiring ICU care or additional interventions&#46; We only focused on the quantitative monitoring of the neuromuscular junction function as the key for the safe management of the nondepolarizing neuromuscular relaxant&#44; both to evaluate recovery and reversal therapy&#44; given the significant non-correlation between the clinical values and the data of this monitoring exercise&#46;</p><p id="par0225" class="elsevierStylePara elsevierViewall">Although Sugammadex exhibits multiple advantages as compared to Neostigmine&#44;<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">20</span></a> our data may suggest that the major benefit is in situations of profound or intense blockade where the use of Neostigmine is controversial&#46; However&#44; for reversal of recovering patients&#44; the administration of Neostigminemay offer similar results and safety as Sugammadex&#44; except for patients with contraindications or controversial use&#46; Rp and reversal-associated cardiac or respiratory complications were not relevant for the patients in this trial&#46; It should be said however that not all patients underwent pharmacological reversal for Rp&#59; in fact&#44; 46&#46;15&#37; of the cases did not receive any medication since clinical monitoring and oxygen therapy were enough to revert the Rp with no complications&#46; So the question arises&#58; Is reversal of Rp with nondepolarizing neuromuscular relaxants really necessary in patients over 65 years of age&#44; when residual relaxation presents during the recovery phase of neuromuscular relaxation&#63;</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Ethical disclosures</span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Protection of human and animal subjects</span><p id="par0240" class="elsevierStylePara elsevierViewall">The authors declare that no experiments were performed on humans or animals for this study&#46;</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Confidentiality of data</span><p id="par0245" class="elsevierStylePara elsevierViewall">The authors declare that no patient data appear in this article&#46;</p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Right to privacy and informed consent</span><p id="par0250" class="elsevierStylePara elsevierViewall">The authors declare that no patient data appear in this article&#46;</p></span></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Conflict of interest</span><p id="par0230" class="elsevierStylePara elsevierViewall">The authors have no conflicts of interest to declare&#46;</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Funding</span><p id="par0235" class="elsevierStylePara elsevierViewall">This study was funded by the researchers and their research groups&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:13 [
        0 => array:3 [
          "identificador" => "xres679464"
          "titulo" => "Abstract"
          "secciones" => array:5 [
            0 => array:2 [
              "identificador" => "abst0005"
              "titulo" => "Introduction"
            ]
            1 => array:2 [
              "identificador" => "abst0010"
              "titulo" => "Objective"
            ]
            2 => array:2 [
              "identificador" => "abst0015"
              "titulo" => "Methodology"
            ]
            3 => array:2 [
              "identificador" => "abst0020"
              "titulo" => "Results"
            ]
            4 => array:2 [
              "identificador" => "abst0025"
              "titulo" => "Conclusions"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec685423"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres679465"
          "titulo" => "Resumen"
          "secciones" => array:5 [
            0 => array:2 [
              "identificador" => "abst0030"
              "titulo" => "Introducci&#243;n"
            ]
            1 => array:2 [
              "identificador" => "abst0035"
              "titulo" => "Objetivo"
            ]
            2 => array:2 [
              "identificador" => "abst0040"
              "titulo" => "Metodolog&#237;a"
            ]
            3 => array:2 [
              "identificador" => "abst0045"
              "titulo" => "Resultados"
            ]
            4 => array:2 [
              "identificador" => "abst0050"
              "titulo" => "Conclusiones"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec685424"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        5 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Materials and methods"
        ]
        6 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Results"
        ]
        7 => array:2 [
          "identificador" => "sec0020"
          "titulo" => "Discussion"
        ]
        8 => array:2 [
          "identificador" => "sec0025"
          "titulo" => "Conclusions"
        ]
        9 => array:3 [
          "identificador" => "sec0040"
          "titulo" => "Ethical disclosures"
          "secciones" => array:3 [
            0 => array:2 [
              "identificador" => "sec0045"
              "titulo" => "Protection of human and animal subjects"
            ]
            1 => array:2 [
              "identificador" => "sec0050"
              "titulo" => "Confidentiality of data"
            ]
            2 => array:2 [
              "identificador" => "sec0055"
              "titulo" => "Right to privacy and informed consent"
            ]
          ]
        ]
        10 => array:2 [
          "identificador" => "sec0030"
          "titulo" => "Conflict of interest"
        ]
        11 => array:2 [
          "identificador" => "sec0035"
          "titulo" => "Funding"
        ]
        12 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2015-07-08"
    "fechaAceptado" => "2016-04-14"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec685423"
          "palabras" => array:5 [
            0 => "Muscle relaxation"
            1 => "Neuromuscular blocking agents"
            2 => "Recovery room"
            3 => "Aged"
            4 => "Anesthesia"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec685424"
          "palabras" => array:5 [
            0 => "Relajaci&#243;n muscular"
            1 => "Bloqueantes neuromusculares"
            2 => "Sala de recuperaci&#243;n"
            3 => "Anciano"
            4 => "Anestesia"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:3 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Introduction</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Few studies have been made on the incidence of residual paralysis from non-depolarizing relaxants in people over 65 years old&#59; however&#44; estimating the number of cases and treatment thereof are both important&#46;</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Objective</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">To study the incidence of residual paralysis with non-depolarizing relaxants in patients over 65 years of age and discuss treatment&#46;</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Methodology</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Analytical observational study based on a cohort design&#46;</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Results</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">The pre-extubation residual paralysis was estimated at 23&#46;2&#37; and at 9&#46;2&#37; at patient admission to the Recovery Suite&#46; Pharmacological reversal showed 89&#46;4&#37; and 100&#37; success rates with Neostigmine and Sugammadex respectively&#44; with similar times at T4&#47;T1<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>0&#46;9&#46;</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Conclusions</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">The incidence of pre-extubation residual paralysis was lower than the figure published worldwide&#46; Pharmacological reversal therapies were typically highly effective&#46;</p></span>"
        "secciones" => array:5 [
          0 => array:2 [
            "identificador" => "abst0005"
            "titulo" => "Introduction"
          ]
          1 => array:2 [
            "identificador" => "abst0010"
            "titulo" => "Objective"
          ]
          2 => array:2 [
            "identificador" => "abst0015"
            "titulo" => "Methodology"
          ]
          3 => array:2 [
            "identificador" => "abst0020"
            "titulo" => "Results"
          ]
          4 => array:2 [
            "identificador" => "abst0025"
            "titulo" => "Conclusions"
          ]
        ]
      ]
      "es" => array:3 [
        "titulo" => "Resumen"
        "resumen" => "<span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Introducci&#243;n</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">La incidencia de Relajaci&#243;n Residual por relajantes no despolarizantes en mayores de 65 a&#241;os ha sido poco estudiada&#44; siendo relevante su calculo y su tratamiento&#46;</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Objetivo</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Estudiar la incidencia de Relajaci&#243;n residual en pacientes mayores de 65 a&#241;os con relajantes neuromusculares no despolarizantes y describir su tratamiento&#46;</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Metodolog&#237;a</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Estudio Observacional Anal&#237;tico con Dise&#241;o de Cohorte&#46;</p></span> <span id="abst0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Resultados</span><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">La Relajaci&#243;n Residual pre-extubaci&#243;n fue del 23&#46;2&#37; y al ingreso a la Sala de Recuperaci&#243;n del 9&#46;2&#37;&#46; La reversi&#243;n farmacol&#243;gica con Neostigmina exhibi&#243; un &#233;xito del 89&#46;4&#37; y con Sugammadex del 100&#37;&#44; con similares tiempos a una T4&#47;T1<span class="elsevierStyleHsp" style=""></span>&#62;<span class="elsevierStyleHsp" style=""></span>0&#46;9&#46;</p></span> <span id="abst0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Conclusiones</span><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Las incidencias de Relajaci&#243;n Residual pre-extubaci&#243;n y en la Sala de Recuperaci&#243;n fueron mas bajas que las publicadas a nivel mundial&#46; Las terapias de reversi&#243;n farmacol&#243;gica se distinguieron por su alta eficacia&#46;</p></span>"
        "secciones" => array:5 [
          0 => array:2 [
            "identificador" => "abst0030"
            "titulo" => "Introducci&#243;n"
          ]
          1 => array:2 [
            "identificador" => "abst0035"
            "titulo" => "Objetivo"
          ]
          2 => array:2 [
            "identificador" => "abst0040"
            "titulo" => "Metodolog&#237;a"
          ]
          3 => array:2 [
            "identificador" => "abst0045"
            "titulo" => "Resultados"
          ]
          4 => array:2 [
            "identificador" => "abst0050"
            "titulo" => "Conclusiones"
          ]
        ]
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Gonz&#225;lez-C&#225;rdenas VH&#44; Salazar-Ram&#237;rez KJ&#44; Coral-S&#225;nchez GT&#46; Relajaci&#243;n residual postoperatoria en pacientes mayores de 65 a&#241;os en la Unidad de Cuidado Posanest&#233;sico&#46; Rev Colomb Anestesiol&#46; 2016&#59;44&#58;209&#8211;215&#46;</p>"
      ]
    ]
    "multimedia" => array:6 [
      0 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">kg&#58; kilograms&#59; BMI&#58; body mass index&#59; TOF&#58; train of four&#46;</p><p id="spar0095" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">Source</span>&#58; Authors&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Variable&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>228<br>Average &#40;range&#47;ED&#41; or frequency &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Age &#40;years&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">72 &#40;&#177;29&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Gender &#40;male&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">108 &#40;47&#46;4&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Weight &#40;kg&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">60 &#40;&#177;56&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">BMI &#40;kg&#47;m<span class="elsevierStyleSup">2</span>&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">24&#46;64 &#40;&#177;3&#46;29&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Comorbidities&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1 &#40;&#177;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Prior TOF&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">100 &#40;&#177;13&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1115439.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Demographic information and TOF prior to exposure&#46;</p>"
        ]
      ]
      1 => array:8 [
        "identificador" => "tbl0010"
        "etiqueta" => "Table 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at2"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">kg&#58; kilograms&#59; BMI&#58; body mass index&#59; TOF&#58; train of four&#46;</p><p id="spar0100" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">Source</span>&#58; Authors&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Variable&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">With pre-extubation Rp<br>Average &#40;Range&#47;ED&#41;<br>or frequency &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Without pre extubation Rp<br>Average &#40;Range&#47;ED&#41;<br>or Frequency &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">p</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">With PACU Rp<br>Average &#40;Range&#47;ED&#41;<br>or frequency &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Without PACU Rp<br>Average &#40;Range&#47;ED&#41;<br>or frequency &#40;&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">p</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Age &#40;years&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">73&#46;5 &#40;29&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">70 &#40;32&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;132&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">72&#46;5 &#40;37&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">72 &#40;24&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;833&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Gender &#40;male&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">88 &#40;81&#46;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">87 &#40;72&#46;5&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;074&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">99 &#40;91&#46;7&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">108 &#40;90&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;420&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Weight &#40;kg&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">60 &#40;42&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">63 &#40;56&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;127&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">60 &#40;56&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">65 &#40;32&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;172&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">BMI &#40;kg&#47;m<span class="elsevierStyleSup">2</span>&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">24&#46;50 &#40;3&#46;12&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">25&#46;14 &#40;3&#46;8&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;267&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">24&#46;61 &#40;3&#46;31&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">24&#46;97 &#40;3&#46;21&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;636&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Comorbidities&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1 &#40;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1 &#40;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;574&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1 &#40;4&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1 &#40;3&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;737&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Prior TOF&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">100 &#40;10&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">100 &#40;13&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;092&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">100 &#40;10&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">100 &#40;13&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">0&#46;251&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1115435.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Demographic data and TOF prior to exposure according to outcome&#46;</p>"
        ]
      ]
      2 => array:9 [
        "identificador" => "tbl0015"
        "etiqueta" => "Table 3"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "fuente" => "<span class="elsevierStyleItalic">Source</span>&#58; Authors&#46;"
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at3"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Variable&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Pre-extubation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">PACU&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Residual relaxation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">53 &#40;23&#46;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">21 &#40;9&#46;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="left" valign="top"><span class="elsevierStyleItalic">Severity</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Recovering&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">52 &#40;88&#46;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">21 &#40;100&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Profound&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1 &#40;1&#46;9&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0 &#40;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Profound and intense&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0 &#40;0&#46;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0 &#40;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="3" align="left" valign="top"><span class="elsevierStyleItalic">Neuromuscular relaxant</span></td></tr><tr title="table-row"><td class="td" title="table-entry  " align="" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic"><span class="elsevierStyleBold">p</span></span><span class="elsevierStyleBold">&#61;</span><span class="elsevierStyleItalic"><span class="elsevierStyleBold">0&#46;001</span></span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic"><span class="elsevierStyleBold">p</span></span><span class="elsevierStyleBold">&#61;</span><span class="elsevierStyleItalic"><span class="elsevierStyleBold">0&#46;728</span></span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Rocuronium&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">29 &#40;26&#46;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">9 &#40;8&#46;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Cisatracurium&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">14 &#40;14&#46;3&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">9 &#40;9&#46;2&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Vecuronium&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10 &#40;52&#46;6&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3 &#40;15&#46;8&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Pancuronium&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0 &#40;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0 &#40;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1115436.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Residual relaxation&#46;</p>"
        ]
      ]
      3 => array:8 [
        "identificador" => "tbl0020"
        "etiqueta" => "Table 4"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at4"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0110" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleSup">a</span> Estimated Latency of 68&#46;42&#37; of the data&#44; <span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>156&#46;</p><p id="spar0105" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">Source</span>&#58; Authors&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Variable&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Rocuronium&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Cisatracurium&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Vecuronium&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Pancuronium&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Dose&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#46;52<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#40;&#177;0&#46;14&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#46;091<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#40;&#177;0&#46;021&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#46;858<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#40;&#177;0&#46;033&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#46;09<span class="elsevierStyleHsp" style=""></span>mg&#47;kg&#40;&#177;0&#46;014&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ED95&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">25&#46;7&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">49&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">26&#46;3&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">50&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">74&#46;3&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">51&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">73&#46;7&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">50&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Latencia<span class="elsevierStyleSup">a</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2<span class="elsevierStyleHsp" style=""></span>min&#40;&#177;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">6<span class="elsevierStyleHsp" style=""></span>min&#40;&#177;9&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">4<span class="elsevierStyleHsp" style=""></span>min&#40;&#177;6&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">&#8211;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1115438.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">Neuromuscular relaxants &#40;95ED&#58; percentage use at a 95&#37; effective dose&#44;</p>"
        ]
      ]
      4 => array:9 [
        "identificador" => "tbl0025"
        "etiqueta" => "Table 5"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "fuente" => "<span class="elsevierStyleItalic">Source</span>&#58; Authors&#46;"
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at5"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Clinical Criteria&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Pre-extubation&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Admission to the recovery room&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Raising head&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Sensitivity<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>18&#46;75&#37;<br>PPV<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>64&#46;29&#37;<br>Kappa<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>&#8722;0&#46;073&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Sensitivity<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>14&#46;29&#37;&#44;<br>PPV<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>30&#37;&#44;<br>Kappa<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>&#8722;0&#46;022&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Presence of Apnea&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Sensitivity<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>12&#46;5&#37;<br>PPV<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>37&#46;5&#37;<br>Kappa<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>&#8722;0&#46;031&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Sensitivity<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#37;<br>PPV<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#37;<br>Kappa<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;007&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Speaking smoothly&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Sensitivity<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>22&#46;92&#37;<br>PPV&#46;<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>37&#46;93&#37;<br>Kappa<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>&#8722;0&#46;06&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Sensitivity<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>4&#46;76&#37;<br>PPV<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>6&#46;25&#37;<br>Kappa<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;006&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Breathing smoothly&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Sensitivity<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>6&#46;25&#37;<br>PPV<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>30&#37;<br>Kappa<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>&#8722;0&#46;01&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Sensitivity<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>4&#46;76&#37;<br>PPV<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>8&#46;33&#37;<br>Kappa<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#46;002&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1115434.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0085" class="elsevierStyleSimplePara elsevierViewall">Sensitivity&#44; positive predictive value &#40;PPV&#41;&#44; and kappa coefficient for each Rp clinical criterion&#44; based on the time of measurement&#46;</p>"
        ]
      ]
      5 => array:9 [
        "identificador" => "tbl0030"
        "etiqueta" => "Table 6"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "fuente" => "<span class="elsevierStyleItalic">Source</span>&#58; Authors&#46;"
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at6"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Variable&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Neostigmine<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>Atropine&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="center" valign="top" scope="col" style="border-bottom: 2px solid black">Sugammadex&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Pharmacological reversal&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">17 &#40;53&#46;1&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">15 &#40;46&#46;9&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Dose&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">0&#46;04<span class="elsevierStyleHsp" style=""></span>mg&#47;kg &#40;&#177;0&#46;02&#41;<span class="elsevierStyleHsp" style=""></span>&#43;<span class="elsevierStyleHsp" style=""></span>0&#46;72<span class="elsevierStyleHsp" style=""></span>mg&#40;&#177;0&#46;24&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">3&#46;15<span class="elsevierStyleHsp" style=""></span>mg&#47;kg &#40;&#177;0&#46;88&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Effectiveness&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">13 of 15 &#40;88&#46;24&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">15 of 15 &#40;100&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Latency &#40;<span class="elsevierStyleItalic">p&#61;0&#46;522</span>&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">5&#46;07<span class="elsevierStyleHsp" style=""></span>min &#40;&#177;2&#46;58&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">4&#46;29<span class="elsevierStyleHsp" style=""></span>min &#40;&#177;3&#46;82&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1115437.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0090" class="elsevierStyleSimplePara elsevierViewall">Reversal of residual paralysis&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:20 [
            0 => array:3 [
              "identificador" => "bib0105"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "B&#46; Debaene"
                            1 => "B&#46; Plaud"
                            2 => "M&#46;P&#46; Dilly"
                            3 => "F&#46; Donati"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Anesthesiology"
                        "fecha" => "2003"
                        "volumen" => "98"
                        "paginaInicial" => "1042"
                        "paginaFinal" => "1048"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12717123"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0110"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The undesirable effects of neuromuscular blocking drugs"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "C&#46; Claudius"
                            1 => "L&#46;H&#46; Garvey"
                            2 => "J&#46; Viby-Mogensen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-2044.2008.05866.x"
                      "Revista" => array:7 [
                        "tituloSerie" => "Anaesthesia"
                        "fecha" => "2009"
                        "volumen" => "64"
                        "numero" => "Suppl 1"
                        "paginaInicial" => "10"
                        "paginaFinal" => "21"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19222427"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0115"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Residual paralysis after emergence from anesthesia"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "B&#46; Plaud"
                            1 => "B&#46; Debaene"
                            2 => "F&#46; Donati"
                            3 => "J&#46; Marty"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/ALN.0b013e3181cded07"
                      "Revista" => array:6 [
                        "tituloSerie" => "Anesthesiology"
                        "fecha" => "2010"
                        "volumen" => "112"
                        "paginaInicial" => "1013"
                        "paginaFinal" => "1022"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20234315"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0120"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Residual paralysis&#58; a real problem or did we invent a new disease&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "F&#46; Donati"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s12630-013-9932-8"
                      "Revista" => array:7 [
                        "tituloSerie" => "Can J Anesth"
                        "fecha" => "2013"
                        "volumen" => "60"
                        "paginaInicial" => "714"
                        "paginaFinal" => "729"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23625545"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0049017210001782"
                          "estado" => "S300"
                          "issn" => "00490172"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0125"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The RECITE study&#58; a Canadian prospective multicenter study of the incidence and severity of residual neuromuscular blockade"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "L&#46;P&#46; Fortier"
                            1 => "D&#46; McKeen"
                            2 => "K&#46; Turner"
                            3 => "&#201;&#46; de M&#233;dicis"
                            4 => "B&#46; Warriner"
                            5 => "P&#46;M&#46; Jones"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1213/ANE.0000000000000757"
                      "Revista" => array:6 [
                        "tituloSerie" => "Anesth Analg"
                        "fecha" => "2015"
                        "volumen" => "121"
                        "paginaInicial" => "366"
                        "paginaFinal" => "372"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25902322"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0130"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Residual paralysis at the time of tracheal extubation"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "G&#46;S&#46; Murphy"
                            1 => "J&#46;W&#46; Szokol"
                            2 => "J&#46;H&#46; Marymont"
                            3 => "M&#46; Franklin"
                            4 => "M&#46;J&#46; Avram"
                            5 => "J&#46;S&#46; Vender"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1213/01.ANE.0000151159.55655.CB"
                      "Revista" => array:6 [
                        "tituloSerie" => "Anesth Analg"
                        "fecha" => "2005"
                        "volumen" => "100"
                        "paginaInicial" => "1840"
                        "paginaFinal" => "1845"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15920224"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0135"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A survey of current management of neuromuscular block in the United States and Europe"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "M&#46; Naguib"
                            1 => "A&#46;F&#46; Kopman"
                            2 => "C&#46;A&#46; Lien"
                            3 => "J&#46;M&#46; Hunter"
                            4 => "A&#46; Lopez"
                            5 => "S&#46;J&#46; Brull"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1213/ANE.0b013e3181c07428"
                      "Revista" => array:6 [
                        "tituloSerie" => "Anesth Analg"
                        "fecha" => "2010"
                        "volumen" => "111"
                        "paginaInicial" => "110"
                        "paginaFinal" => "119"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19910616"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0140"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A&#46; Butterly"
                            1 => "E&#46;A&#46; Bittner"
                            2 => "E&#46; George"
                            3 => "W&#46;S&#46; Sandberg"
                            4 => "M&#46; Eikermann"
                            5 => "U&#46; Schmidt"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/bja/aeq157"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Anaesth"
                        "fecha" => "2010"
                        "volumen" => "105"
                        "paginaInicial" => "304"
                        "paginaFinal" => "309"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20576632"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0145"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Intraoperative neuromuscular monitoring site and residual paralysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "S&#46;R&#46; Thilen"
                            1 => "B&#46;E&#46; Hansen"
                            2 => "R&#46; Ramaiah"
                            3 => "C&#46;D&#46; Kent"
                            4 => "M&#46;M&#46; Treggiari"
                            5 => "S&#46;M&#46; Bhananker"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/ALN.0b013e31826f8fdd"
                      "Revista" => array:6 [
                        "tituloSerie" => "Anesthesiology"
                        "fecha" => "2012"
                        "volumen" => "117"
                        "paginaInicial" => "964"
                        "paginaFinal" => "972"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23001053"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0150"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Residual neuromuscular blockade affects postoperative pulmonary function"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "G&#46;V&#46; Kumar"
                            1 => "A&#46;P&#46; Nair"
                            2 => "H&#46;S&#46; Murthy"
                            3 => "K&#46;R&#46; Jalaja"
                            4 => "K&#46; Ramachandra"
                            5 => "G&#46; Parameshwara"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/ALN.0b013e3182715b80"
                      "Revista" => array:6 [
                        "tituloSerie" => "Anesthesiology"
                        "fecha" => "2012"
                        "volumen" => "117"
                        "paginaInicial" => "1234"
                        "paginaFinal" => "1244"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23090145"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0155"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Residual neuromuscular block&#58; lessons unlearned&#46; Part I&#58; definitions&#44; incidence&#44; and adverse physiologic effects of residual neuromuscular block"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "G&#46;S&#46; Murphy"
                            1 => "S&#46;J&#46; Brull"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1213/ANE.0b013e3181da832d"
                      "Revista" => array:7 [
                        "tituloSerie" => "Anesth Analg"
                        "fecha" => "2010"
                        "volumen" => "111"
                        "paginaInicial" => "120"
                        "paginaFinal" => "128"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20442260"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0140673604166762"
                          "estado" => "S300"
                          "issn" => "01406736"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0160"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Residual neuromuscular block in elderly patients after surgical procedures under general anaesthesia with rocuronium"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "P&#46; Pietraszewski"
                            1 => "T&#46; Gaszynski"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.5603/AIT.2013.0017"
                      "Revista" => array:6 [
                        "tituloSerie" => "Anaesthesiol Intensive Ther"
                        "fecha" => "2013"
                        "volumen" => "45"
                        "paginaInicial" => "77"
                        "paginaFinal" => "81"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23877899"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0165"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents&#46; II&#58; The Stockholm revision"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "T&#46; Fuchs-Buder"
                            1 => "C&#46; Claudius"
                            2 => "T&#46; Skovgaard"
                            3 => "I&#46; Eriksson"
                            4 => "K&#46; Mirakhur"
                            5 => "J&#46; Viby-Mergensen"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1399-6576.2007.01352.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Acta Anaesthesiol Scand"
                        "fecha" => "2007"
                        "volumen" => "51"
                        "paginaInicial" => "789"
                        "paginaFinal" => "808"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17635389"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0170"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Can acceleromyography detect low levels of residual paralysis&#63; A probability approach to detect a mechanomyographic train-of-four ratio of 0&#46;9"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "F&#46; Capron"
                            1 => "F&#46; Alla"
                            2 => "C&#46; Hottier"
                            3 => "C&#46; Meistelman"
                            4 => "T&#46; Fuchs-Buder"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Anesthesiology"
                        "fecha" => "2004"
                        "volumen" => "100"
                        "paginaInicial" => "1119"
                        "paginaFinal" => "1124"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15114208"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0175"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Monitoring neuromuscular block&#58; an update"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "T&#46; Fuchs-Buder"
                            1 => "J&#46;U&#46; Schreiber"
                            2 => "C&#46; Meistelman"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-2044.2008.05874.x"
                      "Revista" => array:7 [
                        "tituloSerie" => "Anaesthesia"
                        "fecha" => "2009"
                        "volumen" => "64"
                        "numero" => "Suppl 1"
                        "paginaInicial" => "82"
                        "paginaFinal" => "89"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19222435"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0180"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Current recommendations for monitoring depth of neuromuscular blockade"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "C&#46;A&#46; Lien"
                            1 => "A&#46;F&#46; Kopman"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Curr Opin Anesthesiol"
                        "fecha" => "2014"
                        "volumen" => "27"
                        "paginaInicial" => "616"
                        "paginaFinal" => "622"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0185"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Variabilidad cl&#237;nica del Vecuronio&#46; Experienciaenunainstituci&#243;nen Colombia"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "L&#46; Reyes"
                            1 => "L&#46; Mu&#241;oz"
                            2 => "D&#46; Orozco"
                            3 => "C&#46; Arias"
                            4 => "V&#46; Vergel"
                            5 => "A&#46; Valencia"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Rev Colomb Anestesiol"
                        "fecha" => "2012"
                        "volumen" => "40"
                        "paginaInicial" => "251"
                        "paginaFinal" => "255"
                        "itemHostRev" => array:3 [
                          "pii" => "S1699258X11001720"
                          "estado" => "S300"
                          "issn" => "1699258X"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0190"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans&#58; pharyngeal video radiography and simultaneous manometry after atracurium"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "E&#46; Sundman"
                            1 => "H&#46; Witt"
                            2 => "R&#46; Olsson"
                            3 => "O&#46; Ekberg"
                            4 => "R&#46; Kuylenstierna"
                            5 => "L&#46;I&#46; Eriksson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Anesthesiology"
                        "fecha" => "2000"
                        "volumen" => "92"
                        "paginaInicial" => "977"
                        "paginaFinal" => "984"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10754616"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0195"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Postoperative residual neuromuscular block&#58; a survey of management"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Baillard"
                            1 => "C&#46; Cle&#263;h"
                            2 => "J&#46; Catineau"
                            3 => "F&#46; Salhi"
                            4 => "G&#46; Gehan"
                            5 => "M&#46; Cupa"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/bja/aei240"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Anaesth"
                        "fecha" => "2005"
                        "volumen" => "95"
                        "paginaInicial" => "622"
                        "paginaFinal" => "626"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16183681"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0200"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Sugammadex en paciente neonatal"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "V&#46;H&#46; Gonz&#225;lez"
                            1 => "F&#46; Munar"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Rev Colomb Anestesiol"
                        "fecha" => "2013"
                        "volumen" => "41"
                        "paginaInicial" => "171"
                        "paginaFinal" => "174"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/22562087/0000004400000003/v1_201607020109/S2256208716300244/v1_201607020109/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "951"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Scientific and Technological Research"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/22562087/0000004400000003/v1_201607020109/S2256208716300244/v1_201607020109/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2256208716300244?idApp=UINPBA00004N"
]

Article information

ISSN: 22562087
Original language: English

DOI:10.1016/j.rcae.2016.04.008

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 November	8	1	9
2024 October	37	4	41
2024 September	26	6	32
2024 August	27	12	39
2024 July	20	6	26
2024 June	16	2	18
2024 May	17	2	19
2024 April	21	5	26
2024 March	47	5	52
2024 February	21	2	23
2024 January	44	5	49
2023 December	39	7	46
2023 November	49	15	64
2023 October	28	3	31
2023 September	36	1	37
2023 August	31	5	36
2023 July	17	4	21
2023 June	19	9	28
2023 May	11	1	12
2023 April	4	1	5
2023 March	8	2	10
2023 February	15	2	17
2023 January	29	3	32
2022 December	15	4	19
2022 November	19	3	22
2022 October	8	7	15
2022 September	14	8	22
2022 August	13	12	25
2022 July	12	5	17
2022 June	8	8	16
2022 May	11	8	19
2022 April	7	9	16
2022 March	7	4	11
2022 February	9	6	15
2022 January	6	6	12
2021 December	9	9	18
2021 November	6	7	13
2021 October	12	9	21
2021 September	11	7	18
2021 August	6	5	11
2021 July	7	11	18
2021 June	12	3	15
2021 May	9	7	16
2021 April	25	14	39
2021 March	17	4	21
2021 February	14	6	20
2021 January	10	7	17
2020 December	4	4	8
2020 November	7	5	12
2020 October	5	5	10
2020 September	11	6	17
2020 August	11	6	17
2020 July	11	9	20
2020 June	9	4	13
2020 May	14	5	19
2020 April	11	3	14
2020 March	2	1	3
2020 February	9	2	11
2020 January	6	5	11
2019 December	8	7	15
2019 November	5	2	7
2019 October	5	3	8
2019 September	5	1	6
2019 August	1	0	1
2019 July	5	3	8
2019 June	4	5	9
2019 May	0	17	17
2019 April	1	0	1
2018 December	1	0	1
2018 September	1	0	1
2018 June	4	3	7
2018 May	23	6	29
2018 April	29	5	34
2018 March	18	10	28
2018 February	19	5	24
2018 January	20	5	25
2017 December	22	5	27
2017 November	16	4	20
2017 October	17	12	29
2017 September	26	7	33
2017 August	9	4	13
2017 July	21	5	26
2017 June	18	5	23
2017 May	24	8	32
2017 April	36	13	49
2017 March	13	4	17
2017 February	11	1	12
2017 January	8	7	15
2016 December	35	12	47
2016 November	27	16	43
2016 October	48	17	65
2016 September	73	9	82
2016 August	85	11	96
2016 July	41	13	54

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter